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ABSTRACT  
 
 
 
Reducing Stress in Sheep by Feeding the Seaweed Ascophyllum nodosum. 
 (August 2005) 
Gregory Scott Archer, B.S., Virginia Polytechnic and State University; 
          M.S., Texas A&M University 
Chair of Advisory Committee: Dr. Ted Friend  
 
 
 
Feeding the extract of the seaweed Ascophyllum nodosum (ANOD) has been 
shown to mediate the response of livestock to certain environmental stressors.  To 
determine if feeding ANOD is useful in alleviating handling and transport stress, two 
trials were conducted.  The dose response trial was conducted to determine at which rate 
ANOD should be fed to obtain beneficial results.  Forty-four lambs received ANOD at 
either 0 (control), 0.5, 1, or 2% of dry matter intake per day (approximately 0, 0.25, 0.5, 
and 1 g/kg of body wt per day).  Sheep were administered ANOD twice daily for 14d.  
After 14d of supplementation, IgG and IgM antibody response to ovalbumin was 
reduced by ANOD.  The sheep fed at the 2% rate had a narrower range of body 
temperature during transport than controls.  The 2% rate also had lower body 
temperatures than the controls during times when the thermal heat index was above 80.  
The sheep fed the 2% rate had lower cortisol and aldosterone concentrations during 
walking and transport compared to the controls.  Post transport, sheep supplemented at 
the 1 or 2% rates were less dehydrated as indicated by plasma chemistry profiles and 
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electrolyte concentrations.  In a subsequent trial, the major components of the ANOD 
(fucoidan, salt, and betaine) were fed to determine which, if any, were responsible for 
the treatment effects in the dose response trial.  After 14d supplementation, the salt and 
ANOD sheep had a depressed IgG and IgM antibody response to ovalbumin and an 
increase in white blood cell counts and lymphocyte numbers compared to controls.  The 
ANOD sheep were generally lower in body temperature than the other treatments during 
transport.  The ANOD and salt sheep had lower cortisol concentrations compared to 
controls.  At the end of transport, sheep supplemented with ANOD or salt had lower 
electrolyte concentrations than control sheep.  Supplementation with ANOD was 
associated with lowered body temperature; however, it also suppressed antibody titer 
which could leave animals susceptible to bacterial infection.  The lowered antibody 
production is of concern and needs further study before ANOD can be recommended as 
a useful stress management tool.   
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 INTRODUCTION  
The processes of handling and transporting livestock are known to be stressful 
events for livestock (Kent, 1997; Broom, 2003; Cockram, 2004; Dwyer and Bornett, 
2004).  Numerous research projects have sought to reduce or alleviate this stress.  
Researchers have administered injections of tyrosine or naloxone (Tayeb and Marzouki, 
1992; Ali et al., 2001), investigated the effect that stocking density (Tarrant, 1990; 
Cockram et al., 1996), the orientation of animals (Clark et al., 1993; Toscano and Friend, 
2001), the length of transportation, the road texture (Hall et al., 1998c; Ruiz del la Torre 
et al., 2001), and rest periods (Ibanez et al., 2002) as means to reduce stress.  However, 
most of these factors are difficult to control within the animal industry.  If animals could 
be fed a supplement prior to transport that could alleviate some of the causes of stress 
during transport while also improving the health of the animals, such a supplement 
would be extremely valuable to producers. 
An extract of the seaweed Ascophyllum nodosum (ANOD) has been shown to 
have positive effects on an animal’s physiology during hot weather and in relation to 
fescue toxicity (Allen et al., 2001b).  Some of these positive effects could decrease the 
stress and/or increase the welfare of animals being transported during hot weather.   
Two trials were conducted to ascertain whether ANOD would be a useful to 
reduce stress during transport and handling.  The first trial was a dose response trial that 
determined if ANOD influenced the physiology of sheep under exercise and transport 
stress, thereby reducing stress and mediating body temperature and hydration.  An 
_______________ 
This dissertation is in the style and format of the Journal of Animal Science. 
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additional objective was to determine if supplementation would impact growth and 
humoral immune response in sheep.  The objective of the second trial was to determine 
which ANOD component(s) (salt, fucoidan, or betaine) caused any effects seen during 
the dose response trial. 
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LITERATURE REVIEW 
 The objectives of this study were to determine if stress could be reduced and 
health improved during handling and transport by supplementing the diet with ANOD 
prior handling and transport.  The following review will discuss the common 
physiological variables used to assess stress and health.   
 
General stress response  
            Stress occurs whenever an individual is presented with a challenge to 
homeostasis, in the form of a physiological or psychological stimulus (Chrousos and 
Gold, 1992).  The stress response is necessary for coping with stressors; without the 
stress response animals can suffer dire consequences, possibly even death, should the 
stress response continue indefinitely.  This illustrates the delicate balance of the stress 
response.  When conditions are favorable animals can spend energy towards functions 
such as eating.  If unfavorable conditions arise the stress response allows animals to 
survive a stressful situation until they can escape it.  When stress becomes excessive an 
animal’s adaptive responses are relatively stereotypic and non-specific, which Selye 
termed “the general adaptation syndrome” (Tsigos and Chrousos, 2002).  Selye 
hypothesized there were three stages in the stress response; alarm, resistance, and 
exhaustion.  In the first stage, the body prepares to deal with the stressor.  In the second 
stage, the body seeks to return to homeostasis.  If stressors are not removed, then the 
body will not return to homeostasis, but will enter the third stage, exhaustion, in which 
the body function begins to breakdown.  During stress cardiac output and respiration are 
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accelerated, catabolism increases, and blood flow is redirected to the brain, heart, and 
muscles (Tsigos and Chrousos, 2002).  Without an outlet to appropriately respond to the 
stressor, problems arise for the animal as it enters the exhaustion stage of the stress 
response.  Normally the stress response is time limited, therefore, making the anti 
reproductive, anti growth, catabolic, and immunosuppressive effects of the stress 
response temporarily beneficial.  Unfortunately, many common practices related to 
livestock production put animals in situations they can not alleviate and the normally 
beneficial results of the stress response become damaging.  This extreme response may 
eventually lead to death if the stress response doesn’t end.  In order to ease the problems 
associated with the stress response, one must first understand what physiological 
reactions occur during stress. 
When an individual is undergoing stress, multiple pathways are activated.  The 
two main effector pathways are the hypothalamic-pituitary-adrenal (HPA) axis and the 
sympathetic neurohypothalamus.  These two pathways also interact with higher areas of 
the brain which influence anticipatory phenomena (mesocortical/mesolymbic systems), 
the initiation, propagation, and termination of the stress response 
(amygdala/hippocampus complex), and the sensing of pain (arcuate nucleus) (Tsigos and 
Chrousos, 2002).  If the stress is short term, alarm or emergency, the neurohypothalamus 
is activated, causing a release of the neurotransmitter acytcholine which has receptors on 
the adrenal medulla.  When these receptors are activated, it causes the chromaffin cells 
to release epinephrine.  Epinephrine, a catecholamine, together with norepinephrine, is 
secreted during times of fear or anger and results in increased heart rate and the 
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hydrolysis of glycogen to glucose.  This reaction, often called the "fight or flight" 
response, prepares the body for strenuous activity.   
If the stress is long-term, then the limbic system is activated, causing the 
hypothalamus to secrete the corticotrophic releasing factor (CRH).  This prompts the 
pituitary to release adrenocorticotropic hormone (ACTH) and beta-endorphin.  The beta-
endorphin acts on the brain as a possible form of analgesia.  ACTH causes the zona 
fascilulata and zona reticularis of the adrenal gland to release glucocorticoids (Swenson, 
1993).  Glucocorticoids, such as cortisol, participate in the control of the body’s 
homeostasis and the animal’s response to stress (Tsigos and Chrousos, 2002).  
Glucocorticoids negatively feed back on the secretion of ACTH in order to limit the 
duration of the exposure of body tissues to glucocorticoids.  This negative feedback 
minimizes the catabolic, anti reproductive, immunosuppressive affects of these 
hormones.  Other negative feed back compounds include γ-amino-butyric acid (GABA), 
corticotrophin, and several opioid peptides (Tsigos and Chrousos, 2002).  Acetylcholine 
and serotonin excite CRH neurons and sympathetic neurons (Tsigos and Chrousos, 
2002).  While the normal stress response allows animals to deal with stress until they can 
escape it, this does not always occur during livestock production.   
 
Effect on immunity.  The stress and the hormones released during stress impact 
both the cellular and humoral immune response (Galliard, 2001; Murray et al., 2001; 
Webster, Tonelli, and Sternberg, 2002; Beishuizen and Thijs, 2004).   Stress affects the 
immune system by directly interacting with the parts of the nervous system that 
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innervate peripheral immune organs.  For example, noradrenergic fibers, fired during 
stress, have been documented to be located in the thymic cortex (Khansari et al., 1990) 
and developing thymocytes have been shown to possess adrenoreceptors that respond to 
the hormones released during stress by altering T-cell receptors.  It is also suspected that 
there is an interaction between the noradrenaline releasing nerve fibers that run adjacent 
to in the spleen and macrophages, T-cells, and B-cells (Khansari et al., 1990).  Stress has 
been demonstrated to increase the number of CD4+ lymphocytes while decreasing 
CD8+ lymphocytes (Degabriele and Fell, 2001).  Changes in gene expression due to 
gluccocorticoids and catecholamines disregulate the immune system (Padgett and 
Glaser, 2003). 
One of the primary categories of hormones investigated during stress research is 
glucocorticoids, i.e. cortisol.  Cortisol exerts both permissive and regulatory effects, with 
the permissive effects allowing other hormones maintaining homeostasis to function at a 
normal level.  The regulatory effects, in turn, prevent over reaction of the central 
immune system and other systems to challenges of homeostasis.  Cortisol does this by 
suppressing cell-mediated immune events (Westley and Kelley, 1984, Bauer et al., 
2001).  Large infrequent pulses of cortisol cause modification to the cellular immune 
response (Rhind et al., 1999).  Stressful events, such as mixing animals or transporting 
them, has been demonstrated to lower cell mediated immune response (Sevi et al., 2001).  
The stress of sudden weaning may lead to higher coccidial infestations than in gradually 
weaned sheep (Orgeur et al., 1998) an indication of lowered humoral immunity.  
Cortisol is required in low concentrations for normal development of T cells in the 
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thymus (Pruett, 2001) and modulates the transcription of many cytokines.  Cortisol 
suppresses the pro-inflammatory cytokines IL-1, IL-2, IL-6, IL-8, IL-11, IL-12, TNF-α, 
IFN-γ, and GM-CFS.  Gluccocorticoids also up regulate the anti-inflammatory cytokines 
IL-4, IL-10, and TGF-β (Graham, 1999; Elenkov and Chrousos, 2002; Webster et al., 
2002).  Raised cortisol concentrations during stress cause a decrease in NK cells and 
lymphocytes, diminish mitogen-induced lymphocyte stimulation, and redistribute T cells 
from circulation to the bone marrow (Speirs, 1992).  
Cortisol also inhibits acetylcholine release.  While norepinepherine is released to 
prime the body for the fight or flight response, acetlycholine is released to help calm an 
individual.  While acetlycholine is inhibited by cortisol, during stress, norepinephrine is 
free to compromise the immunity of the individual.  Beta endorphin, another compound 
released during stress, is thought to enhance cytotoxic T and NK cell activity and 
proliferation (Speirs, 1992).  Another hormone released during stress is prolactin.  
Prolactin is thought to have immunodulatory role in two ways:  first, by stimulating the 
immune system directly, and second, by reducing the degree to which gluccocorticoids 
are secreted in response to stress (Davis, 1998). 
 
            Effects of handling (exercise) stress.  One instance during livestock production 
where animals are often put under stress is during handling (exercise) (Pearson et al., 
1977).  Processes of handling sheep such as shearing and loading have been 
demonstrated to be stressful (Hargreaves and Hutson, 1990; Parrott et al., 1998a; Mears 
et al., 1999).  If handling of livestock becomes intense and lasting it is similar to 
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exercise.  During exercise or vigorous activity, the body is under stress because of 
increased energy demand.  Exercise causes an increase in the body temperature of sheep 
(Buckler, 1971; Laburn et al., 2002).  During a period of exercise, the body first 
increases the out put of cortisol (Rudolph and McAuley, 1998) to mobilize sugar stores.  
It eventually depletes the cortisol stores in the body if the exercise continues for a long 
period (de Diego Acosta et al., 2001).  
 
Effects of transport stress.  Transport is a very stressful part of livestock 
production which can also lead to an increase in body temperature (Ingram et al., 2002; 
Kumar et al., 2002).  Many factors contribute to stress during transport and each species 
has a different stress response to transport (Manteca and de la Torre, 1996).  It has been 
demonstrated that excessively high stocking density during transport leads to increased 
injury and stress (Tarrant, 1990; Cockram et al., 1996).  The initial period of transport is 
the most stressful time for animals (Knowles et al., 1995; Broom et al., 1996).  The 
stress of transport has been shown to cause lower carcass yields and dark cutters in cattle 
(Tarrant, 1990; Warriss, 1990).   Orientation during transport had no effect on stress 
levels, but transport is stressful and orientation affects balance during transport (Clark et 
al., 1993; Toscano and Friend, 2001).  Driver behavior and road quality are also factors 
affecting sheep during transport (Cockram et al., 2004). 
 
 Effects of heat stress.  Numerous environmental factors (i.e., temperature, 
crowding, etc.) contribute to the stresses of handling and transport.  Heat stress is a main 
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issue in the welfare of livestock.   An increase in core body temperature in response to 
environmental stress has been documented in numerous species (Ingram et al., 2002).  
This stress-induced hyperthermia has been used to assess the stressfulness of 
management practices in sheep (Parrott et al., 1999) and goats, with respiration rate also 
being used in goats (Kasa et al., 1995).  Though ruminants have a mechanism for 
thermoregulation, they do not maintain a strict body temperature (McLean et al., 1983).  
Cattle, for example, show a diurnal range of 3˚C in body temperature (Finch, 1984).  
Research has shown that hyperthermia has negative effects on the production of 
livestock (Finch, 1984).  Animals go through four stages in an attempt to regulate 
hyperthermia.  The first is the innocuous stage, where the thermo regulation begins in 
response to external temperatures.  The second is the aversive stage, in which the animal 
is coping with the external temperatures, but with difficulty.  The third stage is the 
noxious stage, in which body temperature increases and the fitness of the animal is 
decreased.  The final stage is the extreme stage, in which the body temperature continues 
to rise and if not assuaged, causes the animal to die (Silanikove, 2000).  A method for 
assessing the level of heat stress involves use of the thermal heat index (THI).  This 
index is a combination of the temperature and humidity using the following formula: 
THI = (Dry-Bulb Temp. °C) + (0.36 dew point Temp., °C) + 41.2).  When the THI is 
above 72 indicates mild stress, above 80 indicates medium stress, and above 90 indicates 
severe heat stress in cattle (Pennington and Van Devender, 2004). 
In sheep, panting is the major evaporatory heat loss mechanism used to 
counteract heat stress; respiratory frequency correlates with heat loss by evaporation 
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(Hales and Brown, 1974).  When environmental temperatures exceed 25 ºC, sheep 
increase evaporative heat loss via increased respiration and sweating (Degen and 
Shkolnik, 1978).  In the goat, progressive dehydration leads to suppressed sweating and 
increased panting (Baker, 1989).  A panting animal does not lose salt, thereby causing 
electrolyte concentrations to increase as water is lost from the body.   
An increase in electrolytes after long periods of transport indicates dehydration 
(Friend et al., 1998; Shaheen, 2001; Jaber et al., 2004).  Water loss caused by urination 
and thermo regulation contribute to dehydration during heat stress.  Cortisol increases 
during stress cause sheep to suffer from a loss of body water in excess of that associated 
with a loss of electrolytes (Lowe et al., 2002; Parker et al., 2003) as cortisol plays a role 
in water balance within the body.  Finally, increased environmental temperatures have 
been shown to cause a decrease in RBC, WBC, hemoglobin, and hematocrit in sheep (da 
Silva, et al., 1992).  
 
Ascophyllum nodosum 
 
 Ascophyllum nodosum (ANOD) is a brown seaweed originating from the 
coastline of the North Atlantic Ocean, from Nova Scotia to Norway.  ANOD has many 
uses in human and animal nutrition, plant growth, and as an industrial product 
ingredient.  The seaweed ANOD is often used as an ingredient in supplements as a 
vitamin source to improve health and immunity.  Alginic acid, which is extracted from 
ANOD, is used in the form of salts as a viscosity control gelatin and emulsifying agent 
(Sharp, 2005).  The alginic acid contained within ANOD is composed of 65% 
mannuronic acid, 35% guluronic acid the ratio of these components can range between 
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1.40 and 1.95 (Cottrell and Kovacs, 1980). Common food uses for alginates include 
prepared pie fillings, instant mixes and sauces (Sharp, 2005).   
 The ANOD has also been used as a fertilizer for plants.  In fact use of ANOD as 
a soil conditioner began with the first settlements of Maritime Canada (Sharp, 2005).  
Extracts of the ANOD have been shown to be chelating agents which improve the 
utilization of minerals by plants (Lynn, 1972).  Extracts of ANOD have also 
demonstrated increased germination and early growth in seeds (Britton and Nayes, 
1964).  Fescue treated with ANOD has shown increased superoxide dismutae, gluthaione 
reductase, and ascorbate peroxidase (Ayad, 1998).  Increases in α-tocopherol, β-
carotene, superoxide dismutase and asorbic acid have also been seen in turfgrasses 
treated with seaweed (Schmidt and Zhang, 1997; Zhang, 1997, Zhang and Schmidt, 
1999).  An increase in superoxide dismutase has been seen to last throughout the grazing 
season in fescue treated with ANOD (Allen et al., 1997; Fike et al., 2001). 
 The sodium alginates from ANOD are also used in industrial products and 
processes.  They are also used as a component of a sizing solution for liner-board, for 
enhancing the penetration of adhesives, as carrier for fire reactive dyes, and as an 
emulsifier in polishes (Sharp, 2005).  The sodium alginates from ANOD are also used 
for their gelling properties in air fresheners and explosives (Sharp, 2005). 
The seaweed ANOD can also be used as an animal feed additive; it can compose 
up to 5% of the diet of poultry, sheep, cattle, pigs, and horses (Sharp, 2005).  Trace 
elements and vitamins found within ANOD have been shown to affect growth of cattle, 
milk production, color in eggs, and wool color in sheep (Neeb and Jensen, 1965). An 
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extract of the ANOD has been reported to lower core body temperature of cattle in hot 
weather while also stimulating a higher core body temperature in cold weather (Allen et 
al., 2001a,b).  The seaweed ANOD has also demonstrated an increased cell mediated 
immune function in cattle grazing endophyte infected fescue.  Cattle grazing infected 
fescue and treated with an ANOD extract had increased phagocytic activity and major 
histocompatibility complex class II expression compared to cattle not grazing treated 
fescue (Allen et al., 2001b; Saker et al., 2001).  This improved immune function lasted 
while animals were on pasture, during cross-country transport, and throughout 160 d 
finishing period (Allen et al., 2001a).  Saker et al. (2001) did, however, see depression in 
cellular immunity in cattle not feeding on infected fescue when they were fed ANOD 
during the grazing season compared to cattle grazing uninfected fescue and not fed 
ANOD. However, in a separate study, lambs feed hay with ANOD showed enhanced 
monocyte oxidative burst during both short and long periods of heat stress (Saker et al, 
2004).  Steers fed ANOD at 1.5 or 3% of dry matter intake in the feedlot exhibited 
greater immune response to intra dermal injections with phytohemagglutinin than steers 
not fed ANOD (Allen et al., 2001b).    
Supplementation with ANOD has shown promise in lowering stress as well.  
Lactating mares fed ANOD at 1% of dry matter intake had little change in their 
neutrophil: lymphocyte ratio during the 56 d post weaning period; however mares not 
fed ANOD had an increased ratio indicating an increase in stress (Allen et al., 2001b).  
Supplementation with ANOD has also been shown to increase weight gain in swine 
(Turner et al., 2002) and salmon (Gabrielsen and Austreng, 1998).  
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Anti-bacterial characteristics have also been attributed to ANOD.  Vacca and 
Walsh (1954) reported that ANOD had antibacterial properties for 10 bacteria consisting 
of both gram negative and gram positive organisms.  Supplementation with ANOD at 
the 2% rate in cattle reduced the prevalence of E. coli 0157 in both hide swabs and fecal 
samples (Braden et al., 2004).  However, calves given ANOD in water showed no 
lowering in incidence of bronchopneumonia (Allen et al., 2001b).   
Supplementation with ANOD has also demonstrated effects on carcass quality.  
An increase in meat shelf life, as a result of longer color preservation, was seen in cattle 
which grazed on ANOD treated fescue prior to feedlot finishing (Montgomery et al., 
2001).  Steers fed ANOD treated fescue exhibited increased marbling scores (Allen et 
al., 2001a).  Timing of feeding seems to play a role in the marbling score as feeding 
ANOD during the first 10 d in feedlot increased marbling but feeding during the last 14 
d of finishing did not (Allen et al., 2001b).  Other forms of seaweed have also been 
observed to increase feed intake, increase carcass weight, and decrease digestive tract fill 
(Al-Shorepy et al., 2001).   
Seaweeds, such as ANOD, also contain antioxidants (i.e. selenium, vitamin E, 
phenols, vitamin B, zinc, copper, iron, and manganese) which can reduce the effects of 
free radicals that can occur during transport (Miller and Brzezinski-Slebodzinska, 1993).  
Lambs grazing ANOD treated pastures have demonstrated increased serum vitamin A 
and whole blood Se (Fike et al., 2001).  Steers fed ANOD demonstrated concentrations 
of vitamin E in their livers (Montgomery et al., 2001).  Superoxidase dsimutase activity 
was increased in lambs fed ANOD (Saker et al., 2004).  Finally, the glucans contained 
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within seaweed have been shown to stimulate TNF-α in vitro and in vivo (Jelinkova et 
al., 2002). 
Seaweeds contain many biologically active compounds.  For example, ANOD is 
composed of 10% fucoidan (Baardseth, 1970), a complex sulfated polysaccharide that 
has been shown to increase cellular immunity (Maruyama et al., 2003) while also 
decreasing the classical compliment system (Tissot et al., 2003).  This compound has 
also been shown to have anti viral activity, anti bacterial activity, and amplified 
phagocytic activity in shrimp (Chotigeat et al., 2004).  Fucoidan was also shown to have 
anti viral functions in humans (Lee et al., 2004).  In mice, fucoidan has been shown to 
help prevent tumors (Maruyama et al., 2003) and to inhibit the human 
immunodeficiency virus (HIV) (Sugawara et al., 1989).  Fucoidan has been 
demonstrated to stimulate Il-4 and Il-13 production in human breast milk (Eiwegger et 
al., 2004).  These interleukins are important in lymphocyte maturation and influence the 
differentiation of T cells into TH2 cells.  Fucoidan from ANOD shows excellent metal 
binding abilities and binds lead most efficiently of the divalent metal cations (Paskins-
Hurlburt. 1976).  In rats, fucoidan  has renal protecting properties (Zhang et al, 2003). 
The seaweed ANOD also contains 0.03% betaine (Blunden et al., 1992), which 
has been shown to decrease the effects of heat stress in poultry (Sheikh-Hamad et al., 
1994; Zulkifli et al., 2004).   Betaine acts as both an osmolyte and a methyl donor.  As 
an osmolyte, betaine reduces the energy needed to maintain water and ion balance by 
helping cells retain water (Partridge, 2003).  As a methyl donor, betaine suppresses the 
increase of homocyteine (Yagisawa et al., 2004).  Betaine has also been reported to 
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increase growth (Wray-Cahen et al., 2004) and improve carcass quality (Siljander-Rasi 
et al., 2003) in swine, though it did not impact body temperature (Matthews et al., 2001).  
However, in a separate study, betaine lowered body temperature in poultry during heat 
stress (Belay et al., 1992).  Increased feed intake and growth has been seen in prawns fed 
diets containing beatine (Felix and Sudharsan, 2004).  Ducks fed diets containing betaine 
also exhibited increased growth and improved carcass quality (Wang et al., 2004).  In 
cattle, no effect on growth was found when betaine was added to the diet (Loest et al., 
2002).  In humans, betaine has been shown to protect internal organs, thereby preventing 
chronic disease (Craig, 2004).   
Since ANOD is a seaweed, it also consists of 3-4% sodium, 3-4% chloride and 2-
3% potassium (Baardseth, 1970); therefore, it is of interest to see if salt also could 
account for some of ANOD’s possible effects.  Sodium chloride has been shown to have 
positive effects on sheep physiology in response to transport by maintaining electrolyte 
balance (Cole, 1998).  Electrolytes are thought to alleviate the effect of stress due to the 
leakage of plasma glutamic oxaloacetic transaminase from damaged tissue (Apple et al., 
1993).  Electrolyte solutions have also been shown to alleviate the effects of transport 
stress.  Normally during transport, reduced blood pH, glucose concentration, and 
interstitial water, and increases in serum chloride, hemoglobin, urine sodium, and urine 
osmolality are seen; however, electrolyte solutions attenuate these changes (Schaefer et 
al., 1997).  Shaefer et al. (1997) found that electrolyte therapy for transported animals 
resulted in improved live and carcass weights and better meat quality.  However in 
sheep, when sodium chloride intake is high, there is an increase in urinary concentrations 
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of sodium (Meintjes and Engelbrecht, 1993).  Meintjes and Olivier (1992) also found 
that salt loading directly into the rumen in sheep increased water intake, fractional 
turnover of body water, plasma potassium concentration, urine sodium concentration, 
and decreased urine potassium concentration from control values. 
 
Physiological measures of health and stress 
 The common way to monitor the effect of stress on the health of animals is to 
collect physiological measurements.  These measurements include hormone 
concentrations, blood constituents, growth, and immune function.   Hormones are 
produced by the body to maintain homeostasis.   These hormones in turn, can affect 
blood constituents, growth, and immune function.  When animals are under stress, these 
values may be altered from basal levels; they may also be used to measure overall health 
of an animal.  If values are altered from the normal range it can indicate disease states. 
  
 Cortisol.  Blood cortisol concentration has long been used as a measure of stress.   
An animal’s well-being, or homeostasis, is challenged by a series of events in the 
animal’s brain which leads to the secretion of gluccocorticoids from the adrenal cortex 
(Tsigos and Chrousos, 2002).  Cortisol is secreted in a diurnal pattern, with maximum 
secretion in the morning and minimum secretion at night (Ford et al., 2001).  Overall, 
cortisol affects metabolism, muscle and cardiovascular function,  
behavior, and the immune system (Ford et al., 2001).  Plasma cortisol concentrations 
have been documented in sheep in numerous studies (Table 1).  As the studies in Table 1 
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illustrate, under different conditions and in different flocks, cortisol levels can vary 
greatly in sheep.  Cortisol ranged from 2 – 350 ng/ml in these studies and the average 
basal concentration was 10 - 40 ng/ml.   
 
 
 
 Aldosterone.  Another hormone produced by the adrenal gland, aldosterone, can 
be used to assess electrolyte homeostasis.  Aldosterone is produced by the adrenal gland 
and helps maintain the sodium/potassium balance within the body (Rabinowitz, 1996).  
As aldosterone concentration increases, more sodium is retained and more potassium is 
excreted, thereby increasing water re-absorption.  During dehydration due to water loss, 
 
Table 1.  Studies of sheep where blood was collected to determine cortisol concentrations
 
Experimental Cortisol Study 
test concentration  
 ng/ml  
Artificial 
Insemination 50-350 Khalid et al., 1998 
Basal 10-15 Parker et al., 2003 
Handling 22-78 Pearson et al., 1977 
Isolation 20-100 Apple et al, 1993 
Loading 2-13 Parrott et al., 1998a 
Shearing 58-79 Hargreaves and Hutson, 1990 
Shearing 20-80 Mears et al.,  1999 
Transport 15-54 Parrott et al., 1998b 
Transport 21-27 Hall et al., 1998a 
Transport 2-18 Hall et al., 1998b 
Various 10-100 Mears and Brown, 1997 
Weaning 9-15 Orgeur et al., 1998 
Weaning 7-29 Sowinska et al., 2001 
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aldosterone concentrations decrease to maintain plasma osmoality.  Higher than normal 
aldosterone concentrations may indicate:  primary hyperaldosteronism, cardiac or kidney 
disease, Cushing's syndrome,  or a very low sodium diet.  Lower than normal 
concentrations of aldosterone may indicate:  Addison's disease, very high sodium diet, 
congenital adrenal hyperplasia, or hyporeninemic hypoaldosteronism.  During 
dehydration aldosterone concentrations in sheep range from 60 to 100 pg/ml and 
normally range from 200 to 250 pg/ml when sheep are properly hydrated (Li et al., 2000; 
McKinley et al., 2000).   
 
Plasma chemistry profile.  Plasma chemistry profiles are an accepted way of 
documenting the overall health of an animal (Kumar et al., 2003).  Chemistry profiles 
are useful as stress can change the normal concentrations of some blood constituents 
such as glucose, total protein, and blood urea nitrogen (BUN).  This occurs because 
during stress, corticosteroid concentrations are increased causing an increase in 
gluconeogenesis and a decrease in protein deposition (Barnett et al., 1983).  The 
following is a list of the constituents measured in a plasma chemistry profile and what 
values outside the normal range indicate about the health status of an animal.   These are 
useful to monitor when feeding ANOD to determine its impact on the health and general 
physiology of animals. 
 Albumin/Globulin (A/G) ratio.  The A/G ratio may be elevated in the following 
situations:  hypothyroidism, high protein or high carbohydrate diet with poor nitrogen 
retention, hypogammaglobulinemia (low globulin), and gluccocorticoid excess (low 
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globulin).  The A/G ratio may also decrease due to liver dysfunction (Swenson, 1993; 
Fenner, 2000). 
Albumin. The liver, using dietary protein, synthesizes albumin. Its presence in 
the plasma creates an osmotic force that maintains fluid volume within the vascular 
space. Low albumin is an indication of poor health.  The normal range for domestic 
sheep is 2.7 – 3.7 g/dl (Aiello, 1998).  Albumin concentrations may be elevated by:  
dehydration, congestive heart failure, poor protein utilization, gluccocorticoid excess, 
and congenital factors.  Albumin concentrations may be decreased by:  dehydration, 
hypothyroidism, chronic debilitating diseases, malnutrition - protein deficiency, dilution 
by excess H2O (polydipsia or IV fluids), renal losses (Nephrotic Syndrome), protein 
losing-enteropathy, skin losses (burns, exfoliative dermatitis), and liver dysfunction 
(Swenson, 1993; Fenner, 2000). 
Aspartate amino-transferase.  Aspartate amino-transferase (AST(SGOT)) is 
released into the circulation following the injury or death of cells, particularly by the 
liver, muscle, and highly metabolic cells.  The normal range for domestic sheep is 49 -
123.3 U/l (Aiello, 1998).  Causes of increased concentrations include:  liver 
inflammation, heart muscle damage, other tissue damage, red blood cell damage, 
malignancy, and drugs.  Causes of decreased concentrations include a vitamin B6 
deficiency or chronic kidney dialysis (Swenson, 1993; Fenner, 2000). 
 Blood urea nitrogen (BUN).  Blood urea nitrogen is a by-product of nitrogen 
(protein) utilization.  The normal range for domestic sheep is 10.3 - 26 mg/dl (Aiello, 
1998).  Causes of increased concentrations include:  renal dysfunction, diabetes mellitus, 
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starvation, dehydration, diarrhea, congestive heart failure, gastrointestinal hemorrhage 
and obstruction, shock, tissue necrosis, third degree burns, renal artery stenosis, renal 
vein thrombosis, urinary tract obstruction, gout, increased protein catabolism, and high 
protein diet.  Causes of decreased concentrations include:  syndrome of inappropriate 
ADH secretion (SIADH), liver or biliary dysfunction, malnutrition, celiac sprue, 
advanced stages of acidosis, zinc deficiency, posterior pituitary hypofunction, anabolic 
hormones, and normal pregnancy (Swenson, 1993; Fenner, 2000). 
Calcium. Plasma calcium reflects the metabolic and hormonal state of the 
individual. Ionic or free calcium is not only the biologically active form of calcium but 
reflects the amount of albumin and the blood pH.  When the blood is acidic, calcium 
becomes ionized and is liberated from plasma proteins.  When the blood is basic, more 
calcium is bound to proteins as well as precipitating out of solution.  The normal range 
for domestic sheep is 9.3 – 11.7 mg/dl (Aiello, 1998).   
Increased concentrations may be due to: primary hyperparathyroidism, secondary 
hyperparathyroidism, tertiary hyperparathyroidism, aluminum induced bone disease, 
familial, drugs, and pheochromocytoma, malignancy, hypophosphatasia, toxic effects of 
non-medicinal metals, granulomatous disease, milk-alkali syndrome, medications, 
epilepsy, Paget's disease, immobilization from any cause, excess ingestion of Vitamin D 
or A, and pregnancy and lactation.  Causes of decreased concentrations may be:  
hypoparathyroidism and magnesium deficiency, ovarian hypofunction, vitamin D 
insufficiency, anticonvulsants, rapid bone deposition, protein malnutrition, digestive 
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dysfunction, renal dysfunction, pancreas dysfunction, pregnancy, and metabolic acidosis 
(Swenson, 1993; Fenner, 2000). 
Creatinine. Creatinine (creat) is formed in muscles from creatine, which is 
formed in the liver. It is a substance that in healthy animals is easily excreted by the 
kidney.  The normal range for domestic sheep is 0.9 - 2 mg/dl (Aiello, 1998).  Causes of 
increased concentrations may be:  renal dysfunction, congestive heart failure, starvation-
dehydration, uncontrolled diabetes, and muscle degeneration.  Causes of decreased 
concentrations include:  muscle atrophy, liver disease, and pregnancy (Swenson, 1993; 
Fenner, 2000). 
Gamma glutamyltransferase. The source of gamma glutamyltransferase (GGT) is 
the liver, making it an excellent and specific indicator of liver damage or problems with 
the drainage of bile in the liver.  The normal range for domestic sheep is 0.9 - 2 U/l 
(Aiello, 1998).  Causes of an increase in the concentration of gamma glutamyltransferase 
include:  hepatic inflammation, myocardial infarction, diabetes mellitus, neurologic 
disease, sepsis, and obstruction of bile ducts. Decreases in gamma glutamyltransferase 
include:  hypothyroid, low magnesium and hypothalamic malfunction (Swenson, 1993; 
Fenner, 2000). 
Globulins.  Globulins are proteins that include gamma globulins (antibodies) and 
a variety of enzymes and carrier/transport proteins.  The gamma fraction usually makes 
up the largest portion of the globulins; therefore, antibody deficiency should be 
suspected when the globulin concentration is low.  The normal range for domestic sheep 
is 3.2 - 5 g/dl (Aiello, 1998).  Globulin concentrations may be elevated in:  chronic 
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infections, liver disease, carcinoid syndrome, rheumatoid arthritis, ulcerative colitis, 
multiple myelomas, leukemias, Waldenstrom's macroglobulinemia, autoimmunity, and 
renal dysfunction.  The plasma globulin concentration may be decreased in:  nephrosis, 
alpha-1 antitrypsin deficiency, acute hemolytic anemia, liver dysfunction, and 
hypogammaglobulinemia/ agammaglobulinemia (Swenson, 1993; Fenner, 2000). 
Glucose.  The normal range for domestic sheep is 44 – 81.2 mg/dl (Aiello, 1998).   
Causes of increased concentrations include:  diabetes mellitus and insulin resistance 
syndromes, thiamine (B1) insufficiency, hemochromatosis, ataxia telangiectasia, 
endocrine hyperfunction, acute and chronic pancreatitis, drugs, and stress.  Causes of 
decreased concentrations are:  excess insulin, impaired glucose tolerance, late/large 
malignancies, endocrine hypofunction, high dose salicylates, protein malnutrition, 
pregnancy, various free radical pathologies, hypochlorhydria, liver dysfunction, and 
hereditary (Swenson, 1993; Fenner, 2000). 
Magnesium.  Plasma magnesium is not reflective of total magnesium stores. 
Unfortunately there is not a good test for magnesium.  The normal range for domestic 
sheep is 2.0 – 2.7 mg/dl (Aiello, 1998).  Increases in magnesium include:  
hypothyroidism, adrenal cortical hypofunction, hyperparathyroidism, and renal 
dysfunction.  Causes of decreased magnesium include:  excessive urinary losses, renal 
dysfunction, hypercalcemia or hypophosphatemia, hyperthyroidism, hyperaldosteronism, 
diuresis, decreased Intake of magnesium, increased intestinal losses, and pancreatitis 
(Swenson, 1993; Fenner, 2000). 
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Phosphorus.  This mineral is essential to the formation of muscle, red blood cells, 
ATP, the maintenance of acid-base balance and lowering blood viscosity, nervous 
system function, and the metabolism of carbohydrates, protein and fat.  The normal 
range for domestic sheep is 4 – 7.3 mg/dl (Aiello, 1998).  Causes of increased 
concentrations are:  renal dysfunction, magnesium deficiency, bone sources, endocrine, 
sarcoidosis, liver dysfunction, diabetes, drug induced, and high calcium concentrations.  
Causes of decreased concentrations are:  intracellular phosphorus shift, alkalosis or 
recovery from acidosis, carbohydrate intake, beta-adrenergic agents, diarrhea, 
malabsorption including hypochlorhydria, nasogastric suctioning, hypomagnesemia, 
hypokalemia, renal disease, diuretics, corticosteroids, xanthine derivatives, protein 
malnutrition, insufficient vitamin D, liver dysfunction, low serum calcium 
concentrations, hyperparathyroidism, and trauma (Swenson, 1993; Fenner, 2000). 
Plasma protein.  Proteins are the most abundant compounds in serum.  Because 
total protein represents the sum of albumin and globulins, it is more important to know 
which protein fraction is high or low than what is the total protein.  The normal range for 
domestic sheep is 5.9 – 7.8 g/dl (Aiello, 1998).  Total protein may be elevated due to: 
chronic infection, adrenal cortical hypofunction, liver dysfunction, collagen vascular 
disease, hypersensitivity states, sarcoidosis, dehydration, respiratory distress, hemolysis, 
cryoglobulinemia, and leukemia.  Total protein may be decreased due to:  malnutrition 
and malabsorption, liver disease, diarrhea, severe burns, loss through the urine in severe 
kidney disease, low albumin, low globulins, and pregnancy (Swenson, 1993; Fenner, 
2000). 
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Electrolytes.  Electrolytes are a useful measure of the hydration of an animal.  
During transport, animals can easily become dehydrated, making hydration monitoring  
an important factor.  It is of interest to examine how ANOD supplementation affects 
hydration level.  The following is a list of commonly measured electrolytes and what 
factors contribute to their abnormal levels. 
Sodium.  Sodium maintains acid-base equilibrium for proper osmotic balance.  
Normally it is the most abundant cation in the fluid outside of the cell.  Sodium is the 
most important factor in osmotic regulation of extra-cellular fluid balance and acid 
balance, as well as renal, cardiac and adrenal functions.  It is needed to maintain the 
sodium-potassium pump, which transports sodium out of the cell and potassium into the 
cell.  The normal range for domestic sheep is 141.6 – 159.6 meq/l (Aiello, 1998).  
Sodium concentrations may be elevated in:  water deficit, diarrhea, diabetes mellitus, 
renal disease, excessive intake of sodium, adrenal cortex hyper-function, pyloric 
obstruction, congestive heart failure, insufficient anti-diuretic hormone production, and 
insufficient parathyroid hormone.  Sodium may be reduced in: pyloric spasm, 
hyperglycemia and diabetes mellitus, excess perspiration, adrenal cortex hypo-function, 
excess progesterone, diarrhea and metabolic alkalosis, and renal dysfunction (Swenson, 
1993; Fenner, 2000). 
Chloride.  Chloride contributes to the body’s acid/base balance. Along with 
sodium, potassium and carbon dioxide, it is important in evaluating acid/base 
relationships, state of hydration, adrenal and renal functions. The normal range for 
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domestic sheep is 100.8 – 113 meq/l (Aiello, 1998).  Causes of increased chloride are:  
metabolic acidosis, renal dysfunction, excess sodium chloride intake, adrenal cortical 
hyperfunction, severe dehydration, diabetes insipidus, hyperparathyroidism, and anterior 
pituitary hypofunction.  Causes of decreased chloride are:  renal chloride loss, GI 
chloride loss, metabolic alkalosis, chronic compensated respiratory acidosis, congestive 
heart failure, over hydration, burns, diabetes, Addison’s disease, hypoparathyroidism, 
and perspiration (Swenson, 1993; Fenner, 2000). 
Potassium.  Potassium is an extremely valuable electrolyte essential to heart and 
kidney function as well as to the maintenance of blood and urine pH.  It is the chief 
electrolyte in the fluid of cells.  The normal range for domestic sheep is 4.6 – 6.3 meq/l 
(Aiello, 1998).  Plasma potassium is increased in:  renal dysfunction, adrenal cortex 
under function, metabolic acidosis, respiratory dysfunction, bradycardia, and diabetes.   
Plasma potassium is decreased in:  diarrhea and/or vomiting, adrenal cortex over 
function, anemia, metabolic alkalosis, and hypertension (Swenson, 1993; Fenner, 2000). 
Na/K ratio. Na/K ratio is an approximate measurement of ions.   The ratio is 
increased when there are excessive anions/acids in the blood. Common causes of an 
elevated Na/K ratio include:  keto acid overproduction, lactic acid, genetic defects of 
enzymes of carbohydrate metabolism, nutritional deficiencies, inability to excrete acids, 
and dehydration. The Na/K ratio is decreased by free radical pathology due to 
overproduction of alkaloids. Other symptoms that have been associated with a reduced 
ratio are:   hyperchloremic acidosis, multiple myeloma, Hypoalbuminemia, and kidney 
disease (Swenson, 1993; Fenner, 2000). 
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 Immunity.  As mentioned earlier, stress impacts immune function. Therefore, 
measuring immune function is an important tool in assessing the effects of stress on an 
animal as well as its overall health.  There are two main components of the immune 
response, cellular and humoral.  These two systems can be altered independently of one 
another and are responsible for removal of different types of antigens, while using 
different components of the immune system to complete their functions. 
Cellular.  Cellular immunity is the effector function of the T lymphocytes.  The 
purpose of cellular immunity is to fight infection by pathogens living within cells, such 
as viruses.  Cellular immunity works by infected cells presenting antigen to the T 
lymphocytes.  The cellular immune response consists of two types of reactions.  The first 
consists of the T lymphocytes producing cytokines after recognizing presented antigens.  
These cytokines activate phagocytes and stimulate inflammation.  The second stage of 
the cellular immune response entailes the cytolitic T lymphocytes causing an infected 
cell to lyse (Abbas et al., 2000). 
Complete Blood Cell Count.  A complete blood cell count is used to assess the 
overall health of an individual.  The differential count of the white blood cells allows an 
assessment of cellular immune function.  The differential examines the specific types of 
white blood cells found within an individual, such as eosoniphils, basophils, etc.  The 
following is a list of the components of the complete blood count and what values 
outside the normal range indicate about an animal’s health status.   
White blood cell count.  The white blood cell count is the measurement of the 
number of leukocytes within the blood.  The normal range for domestic sheep is 4000 – 
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12000/µl (Aiello, 1998).  Low numbers of WBCs may indicate:  bone marrow failure, 
presence of cytotoxic substance, collagen-vascular diseases, and disease of the liver or 
spleen.  High numbers of WBCs may indicate:  infectious diseases, inflammatory 
disease, leukemia, severe emotional or physical stress, and tissue. 
Red blood cell count.  The primary reason to assess the RBC is to check for 
anemia and to evaluate the production of red blood cells.  The mature red blood cell 
carries oxygen attached to the iron in hemoglobin.  The normal range for domestic sheep 
is 9,000,000 – 15,000,000/µl (Aiello, 1998).  The number of red blood cells is increased 
in:  chronic respiratory insufficiency, living at a high altitude, cystic fibrosis, adrenal 
cortical hyper function, and anabolic metabolism. The number of red blood cells is 
decreased in:  iron deficiency, vitamin B6, B12, and/or folic acid deficiency, chronic 
disease, free radical pathology, toxic metals, and catabolic metabolism. 
Packed cell volume.  The hematocrit or packed cell volume (PCV) represents the 
volume of red blood cells in 100ml of blood and is therefore reported as a percentage.  
The normal range for domestic sheep is 27 – 45 % (Aiello, 1998).  A low hematocrit and 
hemoglobin usually indicate decreased production, excessive loss, or destruction of red 
blood cells.  The conditions associated with an increased or decreased hematocrit are the 
same as for hemoglobin.  Transport of sheep has been shown to decrease packed cell 
volume (Hall et al., 1998a). 
Hemoglobin.  Hemoglobin is what gives the blood its characteristic red color. It 
contains iron, which carries the oxygen to the cells.  The hemoglobin concentration 
indicates the amount of intracellular iron; hence, its value in determining anemia. The 
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normal range for domestic sheep is 9 – 15 g/dl (Aiello, 1998).  Hemoglobin is increased 
in:  dehydration, emphysema, severe asthma, macrocytosis, adrenal cortex over activity, 
polycythemia vera, high altitude adaptation, splenic hypofunction, and testosterone 
supplementation.  Hemoglobin is decreased in:  Digestive inflammation, free radical 
pathology, adrenal cortical hypofunction, hereditary anemia, hemodilution, blood loss, 
vitamin or mineral deficiency, chronic disease, and, bone marrow insufficiency. 
Mean corpuscular volume. The MCV relates to the average size of the red blood 
cell.  The normal range for domestic sheep is 28 – 40 fl (Aiello, 1998).  The MCV is 
increased in:  hereditary anemia, reticulocytosis, liver disease, and hypothyroidism.  The 
MCV is decreased in:  copper deficiency, low stomach acid, vitamin C insufficiency, 
vitamin B6 deficiency, rheumatoid arthritis, and iron deficiency. 
Mean corpuscular hemoglobin concentration.  The average hemoglobin 
concentration per unit volume (100 ml) of packed red cells is indicated by MCHC.  The 
normal range for a domestic sheep is 31 – 34 g/dl (Aiello, 1998).  MCHC is increased 
and decreased under the same conditions as the MCV.  
Eosinophil.  Eosinophils are bone marrow derived granulocytes which are 
abundant during hypersensitivity late phase reactions.  They play an important role in the 
defense against extra cellular parasites.  The normal range for domestic sheep is 0 – 
1000/µl (Aiello, 1998).   
Basophil.  Basophils are granulocytes which are recruited into tissue sites where 
antigen is present and may contribute to immediate hypersensitivity reactions. The 
normal range for domestic sheep is 0 – 300/µl (Aiello, 1998).   
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Monocyte.  Monocytes are the precursors to the macrophages.  They are 
recruited to the inflammatory sites where they differentiate into macrophages.  The 
normal range for domestic sheep is 0 – 75/µl (Aiello, 1998).   
Neutrophil.  Neutrophils are the most abundant white blood cell.  They are 
recruited to inflammatory sites and are capable of phagocytising and digesting microbes.  
The normal range for domestic sheep is 700 – 6000/µl (Aiello, 1998).   
Lymphocyte.  Lymphocytes are the B and T cells of the immune system.  They 
are responsible for both the humoral and cellular immune responses, respectively.  The 
normal range for domestic sheep is 2000 – 9000/µl (Aiello, 1998). 
Fibrinogen.  Fibrinogen is a protein produced by the liver which aids in forming 
clots in order to stop bleeding.  The normal range for domestic sheep is 0.1 – 0.5 g/dl 
(Aiello, 1998).   
 Humoral.  The humoral immune response utilizes antibodies to neutralize and 
eliminate microbes that are in the extra cellular spaces, such as bacteria and toxins.  
Antibodies are a structurally related family of glycoprotiens produced by B 
lymphocytes.  Membrane bound antibodies mediate the activation of the B cells.   Once 
activated, B cells secrete antibodies in order to eliminate foreign microbes.  The binding 
region of antibodies are highly variable, allowing individuals to produce 109 different 
antibodies, each of which is antigen specific.  There are also different types of 
antibodies, known as isotypes.  Different isotypes predominate during initial versus 
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secondary exposure to an antigen.  The IgM isotype is the predominating isotype in the 
initial exposure, while IgG predominates during the subsequent exposures. 
The first function of the antibodies produced during a humoral immune response 
is to neutralize the microbe or toxin by binding to them in order to prevent their binding 
to cellular receptors.  Many microbes bind to a specific cellular surface molecule and use 
these to enter the host cells.  Antibodies interfere with this process by binding to the 
microbes, making it physically impossible for the microbe to bind to the host cell; this is 
called “steric hindrance.”  In rare cases, the binding of an antibody to a microbe causes a 
conformational change to the microbe’s surface receptors which prevents the microbe 
from interacting with the host cell. Antibodies block toxins from affecting cells through 
steric hindrance.  Microbes can be neutralized by any isotype as it only involves the 
antigen binding region of the antibody.  The most abundant type of neutralizing antibody 
is IgG.  Many vaccines work by this process of stimulating the production of 
neutralizing antibodies (Abbas et al., 2000). 
 The second function of antibodies is for the opsinization of microbes and to 
promote phagocytosis. Antibodies, specifically IgG, coat antibodies and promote 
phagocytosis by binding the Fc receptor on phagocytes.  Mononuclear phagocytes and 
neutrophils can digest microbes without the aid of antibodies, as they possess surface 
receptors that will bind to the microbes.  However, the phagocytosis is much more 
effective at aiding antibodies as the phagocytes bind to the Fc receptor of the antibody.  
When the Fc is bonded by a phagocyte, it sends signals to the phagocyte to ingest the 
microbe (Abbas et al., 2000). 
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 The third function of antibodies in the humoral immune response is to aid 
natural killer cells in their ability to lyse cells.  The Fc receptor of the natural killer cell 
is called CD16.  When the CD16 is bound by an antibody coated microbe it causes the 
natural killer cell to release cytokines and discharge its granules into the microbe.  These 
granules cause the microbe to lyse thereby killing it (Abbas et al., 2000). 
The final function of antibodies is to activate the compliment system.  The 
compliment system consists of serum and membrane bound proteins which act together 
to create biologically active products.  There are two major pathways of the compliment 
system: classical and alternative.  The classical pathway is activated by antigen-antibody 
complexes, while the alternative pathway is activated by microbial surfaces without 
antibodies.  Both pathways produce enzymes that divide the C3 protein.  The products of 
this enzymatic reaction become covalently bound to microbial surfaces or antibodies.  
The complement system functions to opsonize microbes and immune complexes, leading 
to binding by phagocytes.   The activation of the compliment system enhances the 
humoral immune response (Abbas et al., 2000). 
 The humoral immune response is important in sheep as it is necessary for proper 
immunization and disease resistance.  The common bacterial infections against which 
sheep are vaccinated include:  Clostridium perfringens type C and/or D, Campylobacter 
(Vibrio) fetus intestinalis, Chlamydia psittaci, Leptospira pomona, Leptospira canicola, 
Leptospira hardjo, Leptospira grippotyphosa, Leptospira icterohaemorrhagiae, 
Clostridium tetani, Clostridium chauvoei, Clostridium septicum, and Clostridium novy 
(Grotelueschen, 2005).  These vaccines are usually considered “killed” vaccines, in 
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which the animal is challenged by an innocuous form of the bacteria.  These types of 
vaccines require two doses of the vaccine administered between three and six weeks 
apart.  The initial dose stimulates the immune system to respond to the bacteria but a 
second dose is needed to raise the immunity to a protective level (Rook, 2005).   
 The bacteria Clostridium perfringens type C and/or D causes the disease 
enterotoxemia, commonly called overeating disease, in sheep.  Toxins produced by this 
bacteria cause sudden death in sheep (Grotelueschen, 2005).  Campylobacter (Vibrio) 
fetus intestinalis causes abortions, dead, and weak lambs (Grotelueschen, 2005).  This 
bacterium is the most common cause of abortions in sheep.  Chlamydia psittaci is 
classified as a rickettsia, smaller than bacteria and larger than a virus. This organism 
generally causes abortions, conjunctivitis, arthritis in lambs, epididymitis, pneumonia, 
and diarrhea. It is another major cause of abortions in ewes (Grotelueschen, 2005).  The 
Leptospirosis bacteria cause abortions, anemia, and systemic disease in sheep 
(Grotelueschen, 2005).  Clostridium tetani is a bacterium which inhabits contaminated 
soil and enters the body through open wounds such as castration, tail docking, or 
lacerations. The death rate in lambs is usually over 75% in affected animals. Tetanus 
usually manifests itself as muscle spasms, stiffness, and other nervous system signs 
(Grotelueschen, 2005).  Other clostridial diseases such as Blackleg, Malignant Edema, 
and Braxy are caused by Clostridium chauvoei, Clostridium septicum, and Clostridium 
novyi.  Animals affected by these diseases usually exhibit lameness and subcutaneous 
swelling followed by rapid death (Grotelueschen, 2005). 
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 While these diseases can occur in non stressed animals, stress can intensify the 
susceptibility of animals to other bacterial infections.  Stressful events, such as transport, 
have been shown to lower antibody production in response to ovalbumin intramuscular 
injection (Krawczel et al., 2005).  Heat stress has been shown to lower primary and 
secondary humoral immunity in chicken (Barlett and Smith, 2003).  Emotional stress has 
also been seen to lower humoral immune response to ovalbumin in rats (Shao et al., 
2003).  Social defeat in hamsters leads to a suppression in antibody production (Jasnow 
et al, 2001). 
 This lowered humoral immunity due to stress can leave animals open to bacterial 
infections.  For instance, Bronchopneumonia caused by Pasteurella spp. which affects 
sheep and goats of all ages worldwide, occurs most often in those animals that have 
undergone recent stress such as transportation, weaning, or commingling with animals 
from unrelated farms (Aiello, 1998).  Stress appears to be an important factor in the 
breakdown of respiratory tract defense mechanisms, allowing bacteria to invade lung 
tissue causing pneumonia (Aiello, 1998).  Besides Pasteurella spp., other bacteria such 
as Mycoplasma spp., Chlamydia spp., Haemophilus spp., and Salmonella spp. are 
associated with causing either primary or secondary bronchopneumonia in sheep and 
goats (Aiello, 1998).  Infection with these pathogens is also increased in stressful 
situations.  Another form of pneumonia, shipping fever, which is commonly found in 
cattle can also be found in sheep being transported.  The stress of transport is what 
causes an animals’ susceptibility to shipping fever.  In the year 2000, respiratory 
problems were the fifth leading cause of death in sheep following predators, old age, 
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lambing problems and unknown causes (USDA, Part 1: Reference of Sheep 
Management in the United States, 2001). It is, therefore, necessary to reduce stress and 
improve humoral immune status of animals prior to transport and handling. 
 
Average daily gain in sheep.  Since sheep are raised predominantly for the 
purpose of meat and fiber production, the rate at which they grow is very important.  The 
faster sheep grow, the earlier a producer may sell them.  This has led to many different 
growth supplements and intense breeding for faster growing sheep.  The average daily 
gain of domestic sheep is 0.2 – 0.3 kg/day (Nutrient Requirements of Sheep, 6th ed, 
1985).  If an animal’s growth is depressed from the normal rate, disease or nutrition is 
usually the contributing factor.  It is worthwhile to ascertain the effects of 
supplementation with ANOD on the growth of an animal, as normal growth points to 
good overall health.  
 
Objective 
 Stress during handling and transport is a major problem in the livestock industry, 
especially when it occurs during hot weather.  The health of the livestock is often at risk 
during these procedures.  It would be beneficial to find methods of alleviating the stress 
of these processes, thereby improving the health and well being of the livestock.  Dietary 
supplementation with ANOD has been reported to have many positive effects on 
animals.  The primary objective of this study was to use physiological measurements to 
ascertain if and at what rate ANOD should be fed to animals prior to handling and 
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transport in order to obtain beneficial effects such as mediating body temperature and 
lowering stress.  The secondary objective of this study was to which of the biologically 
active components of ANOD were responsible for the effects observed in the first trial. 
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DOSE RESPONSE TRIAL 
As ANOD has been shown to have beneficial effects on animals during heat 
stress by lowering body temperature and increasing cellular immunity (Allen et al., 
2001a,b), it is of interest to determine if ANOD would be useful in mediating transport 
or handling stress during hot conditions.  Transport often occurs during the hottest 
periods of the year, which raises the stress levels of animals.  The initial goal of this 
project was to establish how much ANOD is needed to obtain benefits during transport 
or handling.   
Methods and materials 
General.  Forty-four crossbred sheep ( 23 ewes and 21 whethers), averaging 26.4 
kg were used in this study.  These sheep were used in a prior transport study (Krawczel 
et al., 2005) six wk earlier, but six wk allowed for sufficient recovery.  The sheep were 
randomly assigned to receive ANOD (Tasco 14, Acardian Agritech, Dartmouth, Nova 
Scotia, Canada) at the rate of 0 (control), 0.5, 1, or 2% of daily dry matter intake (DMI) 
estimated by NRC (Nutrient Requirements of Sheep, 6th ed, 1985), approximately 0, 
0.25, 0.5, and 1 g/kg of body wt per day..  The 2% rate was used in previous studies with 
cattle (Allen et al., 2001b) and the goal was to determine if lower concentrations would 
have the same effects.  Feeding more than 2% was reported to decrease intake in cattle 
when the ANOD was mixed with feed (Allen, personal communication).   
The sheep in this study were kept on pasture and fed a 16% pelleted supplement 
on an ab litum basis.  Twice daily starting on day 0 and continuing until day 14, the 
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sheep were brought down from the pasture to the working pens.  Sheep were then 
administered three gelatin capsules (size 14, Torpac, NJ, USA) containing either the 
appropriate amount of ANOD or their standard grain supplement using a balling gun.  
After receiving boluses, the sheep were released back into the pasture.   
 During the 2 wk ANOD supplementation, the sheep were weighed on day 0, 7, 
and 14 to determine growth rate.  On day 11, all sheep were injected intramuscularly 
(I.M.) in each side of their hindquarters with 0.5 mg ovalbumin (egg protein) suspended 
in 0.25 ml of saline to test humoral immune response (antibody production).  This was a 
booster vaccination as the sheep were given an initial ovalbumin injection in an earlier 
study six wk prior to this study.  Blood samples (10 ml) were taken via jugular vena 
puncture on day 11, 15, and 18.  An indirect ELISA modified from Ameiss et al. (2004) 
was performed on all plasma samples using 96-well plates coated with 5 µg of 
ovalbumin per well.  Following overnight incubation of the coated plates at room 
temperature, plates were blocked with a BSA solution (1X PBS, 0.05% Tween 20, 0.5% 
BSA) for 30 min and then rinsed with PBS-T (pH 7.4, 0.5% Tween 20).  Plates were 
again rinsed and 100 µl of each sample was added to the first and sixth column of the 
plates and serial dilutions were performed for columns 2-5 and 7-10.  The plates were 
then incubated for one h at room temperature after which they were rinsed again and 150 
µl of donkey anti-sheep IgG or chicken anti-sheep IgM (Bethyl Laboratories, 
Montgomery, TX) was added to each well and plates were agitated for one h at room 
temperature.  Plates were rinsed and a substrate solution was added (Immuno Pure TMB 
Substrate kit, Pierce, Rockford, IL).  After 15 min, the reaction was stopped by adding 
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100µl of 2 M sulfuric acid. Absorbance was read by a SunriseÂ® multi-well plate reader 
(Tecan, Austria) at a wavelength of 450 nm.  Positive and negative control samples were 
also run on each plate.  The positive controls were used to standardize the results of each 
plate and were obtained by vaccinating three ewes every three weeks (over a four month 
period) with ovalbumin.  The titer for each ewe was checked and the ewe with the 
highest titer was used for the positive control.   
 
Walking trial. All sheep had temperature data loggers (Thermochrons, 
Maxim/Dallas Semiconductor Corp., Sunnyvale, CA) placed in one of their ear canals to 
measure body temperature on day 14, one hour prior to the walking trial.  Each data 
logger was first placed into the toe of an infant size cotton sock.  The sock was then 
filled with cotton and placed in the ear with the toe as far as possible into the ear canal.  
Next, the ear was taped shut to seal it and to ensure the sock did not fall out during the 
trials.  Loggers were set to record a temperature every 5 min.  At the end of the trial, all 
sheep had their rectal temperature taken using a digital thermometer.   
All sheep were relocated to an enclosed pen (9 X 9 m) formed from a section of 
their home pasture on day 14 at 1300 h.  Sheep were walked in a circular motion around 
a 3 X 3 m rectangular structure within the pen for 30 min in order to increase the body 
temperature of the sheep and to simulate vigorous extended handling.  At the start of the 
walking trials, the environmental temperature was 29.5 ºC.  The sheep were walked at a 
brisk pace until their respiration rate increased and they started panting.  The pace was 
then slowed and maintained for the remainder of the 30 min period.  Increased 
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respiration rates occur during hyperthermia (Hales and Brown, 1974; Entin et al., 1998, 
1999; Friend et al., 1998).  The sheep were then allowed to rest for 30 min to allow 
respiration rates to return to normal, after which the 30 min walk was repeated.  
 Ten ml of blood was taken from all sheep via jugular vena puncture immediately 
prior to the first walking period and immediately after the second walking period.  
Samples were analyzed for cortisol concentration using commercially available RIA kits 
(DPC, Los Angeles, CA).  Duplicates of each plasma sample were assayed and the mean 
concentration was calculated by a computer from a logit-log representation of the 
calibration curve.  First, the program calculated the average of raw counts per minute of 
the two duplicate samples and subtracted from this number the average non-specific 
binding count.  Next, the corrected count was divided by the maximum binding of the 
tracer to get the percent bound.  This percent bound was then compared to the calibration 
curve to get the concentration of cortisol in each sample.  Any duplicates that differed by 
more than 12% were re-assayed.  The intra-assay and inter-assay CV for the cortisol 
assays were less than 9%. 
 
 Transport trial.  Sheep were transported on day 15 over local roads near College 
Station, Tx for 12 h (730-1930) during the month of September in a goose neck trailer.  
Treatments were equally divided into three groups of 15 sheep between three 2.1 X 2.3 
m compartments within the trailer.  An extra sheep, not used in the study, but part of the 
same flock, was used to equalize the stocking density of 15 sheep per compartment.  The 
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external temperature during transport ranged between 19.0-30.7 ºC and the temperature 
inside the trailer ranged between 18.7-32.0 ºC.  
 Temperature loggers were left in the ears of the sheep following the walking trial 
so they could be used to monitor body temperature the next day during transport.  Ten 
ml of blood was taken from all sheep via jugular vena puncture at 0, +4, +8, and +12h of 
transport and on day 18.  Plasma was frozen until analyzed.  All samples were analyzed 
for cortisol and the 0 and +12h samples were analyzed for aldosterone using 
commercially available RIA kits (DPC, Los Angeles, CA).  Any duplicates that differed 
by more than 12% were re-assayed.  The intra-assay and inter-assay CV for the cortisol 
and aldosterone assays were less than 9%.  A portion of the blood sample taken at 0 and 
+12h of transport was used for determination of electrolyte concentrations and plasma 
chemistry profiles by the Texas Veterinary and Medical Diagnostic Laboratory.  Lambs 
were weighed before and prior to being offered feed and water after transport.   
Following transport, the sheep were simultaneously released into a 9 X 9 m pen 
sectioned off from their home pasture; this section contained feed and water troughs.  
The feed was offered in the same round feeder that the sheep fed from daily and two 
additional 4 m troughs were filled with feed (16% pelleted ratio) to allow room for all 
sheep to eat.  The water trough was 1 m long with a float valve for automatic refilling.  
The latency to eat, drink, and lay down was recorded for all sheep by observers.   
 
Statistical analysis.  Humoral immune response and cortisol during transport 
were analyzed following a repeated measures design.  Proc GLM (SAS version 8.2, SAS 
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Institute Inc., USA) was used with treatment, time, and the treatment by time interaction, 
and individual sheep nested within treatment as the factors.  When significant treatment 
by time interactions were found, mean separation was performed using the pdiff 
function.  Average daily gain, cortisol during the walking trial, body temperature, 
plasma chemistry, electrolyte, aldosterone, weight loss, and behavior data were analyzed 
using ANOVA followed by the LSD procedure for post hoc analysis of pair wise 
comparisons.  Significant differences were P < 0.05, unless otherwise stated.  A 
regression analysis was performed on all data to determine dose response (P < 0.05).  
Curve estimation was performed to visualize the best fit for significant dose response 
effects.  
 
Results 
 General.  During the 14 d supplementation period, the sheep fed the 1% rate 
grew at a faster rate (0.30 kg/day) than control sheep (0.15 kg/day, P < 0.05).  This was 
due to the 1% rate having higher (P = 0.06) gain than the control sheep during the 
second week of supplementation.   
 All sheep had similar titers of IgG specific to ovalbumin prior to the booster (d 
11, Table 2).  On day 15, only the control sheep exhibited a normal immune response.  
All other treatments had a significantly lower IgG immune response and this effect was 
dose dependent even at day 18 (Table 2).  The dose response effect for IgG on d 15 was 
linear (P < 0.05) and best fit a cubic line (R2 = 0.37).  A similar effect was also seen in 
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the IgM response, again IgM decreased linearly as dose of ANOD increased (P < 0.05) 
on d 11 and d 15  and best fit a cubic line (R2 = 0.32, 0.32). 
 
Table 2. Mean IgG and IgM titers (absorbance at 450 nm ± SE) of sheep during dose response trial 
  _______________IgG ____________       _____________IgM_______________ 
Treatment Day 11 Day 15 Day 18 Day 11 Day 15 Day 18 
0%  0.43 ± 0.10 2.39abc ± 0.44 1.62ab ± 0.25 1.16± 0.05 1.24abc ± 0.09 1.33ab ± 0.06 
0.5%  0.56 ± 0.11 1.24ad ± 0.45 1.37c ± 0.30 1.26a ± 0.07 0.83a ± 0.12 1.34cd ± 0.07 
1% 0.54 ± 0.11  0.87b ± 0.19 1.09b ± 0.21 1.04 ± 0.04 0.83b ± 0.06 1.01ac ± 0.14 
2% 0.38 ± 0.06 0.17cd ± 0.03 0.62ac ± 0.13 0.91a ± 0.07 0.69c ± 0.09 1.00bd ± 0.17 
Means with same superscript within columns are different (P < 0.05).  
 
 
 Walking Trial.  Ear canal temperature followed rectal temperature, but was 
between 2 and 3 ºC lower (Table 3).  There was no difference between treatments in the 
maximum, minimum, or range in ear canal temperature during the walking trial.  There 
was no treatment effects on rectal temperature response post walking.   
 
 
 
Table 3.   Comparison of ear canal and rectal temperature (ºC ± SE) at the end of walking trial.  
Ear canal temperature (ºC ± SE) range during 12h of transport.   
 ________________Temperature_________________ 
Treatment 
Rectal end 
walk Ear canal end walk Ear canal range transport 
0%   41.18 ± 0.12 38.81 ± 0.13 1.28a ± 0.10 
0.5%   41.18 ± 0.10 38.62 ± 0.11 1.21 ± 0.11 
1%   41.24 ± 0.10 38.59 ± 0.11 1.27 ± 0.18 
2%   41.16 ± 0.09 38.69 ± 0.13 0.92a ± 0.07 
Means with same superscript within columns are different (P < 0.05). 
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 Prior to walking, the control sheep had significantly higher plasma cortisol 
concentrations than those fed the 2% rate of ANOD (Table 4), with the 0.5 and 1% rates 
of ANOD being intermediate, though non-significant, concentrations of cortisol (P = 
0.14, 0.10).  The same trend was true post walk, except for the 0.5% rate of ANOD 
which increased in cortisol concentration. 
 
 
Table 4. Mean cortisol concentration (µg/dl ± SE) pre 
and post walking  
Treatment Pre walk Post walk 
0%  1.90a ± 0.41 1.3 ± 0.28 
0.5%  1.32 ± 0.26 1.54ab ± 0.24 
1%  1.25 ± 0.21 0.87a ± 0.15 
2%  0.97a ± 0.10 0.83b ± 0.15 
Means with same superscript within columns are 
different (P < 0.05). 
 
  
 
Transport Trial.  During the 12 h transport period, all sheep reached similar 
minimum body temperatures (Fig. 1).  The sheep fed at the 2% rate of ANOD had a 
lower maximum body temperature (38.3 ºC, P < 0.05) than the control sheep (38.6 ºC) 
and a lower average body temperature (37.9 ºC, P < 0.05) during hot periods of transport 
(Thermal heat index above 80) than the control sheep (38.2 ºC).  Additionally, the sheep 
fed the 2% rate of ANOD had a significantly smaller range (0.92 ºC) in their body 
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temperature throughout transport compared to the control sheep (1.28 ºC, Table 3).  All 
sheep had similar variation in body temperature throughout transport (avg. 0.12). 
Throughout transport, the control sheep tended to have higher cortisol 
concentrations than the other sheep (Fig. 2).  However, this was significant only at 4 and 
8 h of transport when the control sheep had significantly higher concentrations than the 
sheep fed the 2% rate of ANOD (P = 0.05, 0.10).   
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Higher supplementation lowered pre-transport concentrations of aldosterone 
(Table 5).  After transport all sheep had similar concentrations of aldosterone, except for 
the sheep fed the 1% rate of ANOD which were significantly higher than the other 
treatments for no known reason. 
 
 
Table 5. Aldosterone concentrations (ng/dl ± SE) pre and post 12h transport  
Treatment Pre transport Post transport 
0%  35.34ab± 6.10 16.08a± 1.46 
0.5% 32.14± 4.95 15.70b± 2.15 
1%  22.50a± 3.36 24.75abc± 2.04 
2%  21.99b± 3.41 18.27c± 2.44 
Means with same superscript within columns are different (P < 0.05). 
 
 
There were no differences between treatments in pre-transport plasma chemistry 
profiles.  However, there were many differences in the post transport plasma chemistry 
profile (Table 6).  Generally, plasma protein, albumin, phosphorus, glucose, BUN, 
magnesium, calcium, AST(SGOT), and creatainine were significantly higher in controls 
and/or the sheep fed the 0.5% rate of ANOD than in the sheep fed the 2% rate of ANOD 
and occasionally the 1% rate.  
 The control sheep significantly increased in concentrations of calcium, 
phosphorus, and magnesium post transport (Table 6).  All sheep had significant 
increases in glucose concentrations post transport except the sheep fed the 2% rate of 
ANOD.  The sheep fed the 1% and 2% rates of ANOD also had a significant decrease in 
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their BUN concentrations.  Globulins, CK, the A/G ratio, and gamma 
glutamyltransferase (GGT) were not influenced by treatments and therefore are not 
shown in Table 6. 
 
 
Table 6.  Plasma chemistry panels pre and post 12h of transport 
 
  
P. 
protein   Album.  C P Glucose BUN Creat. 
T. 
bili. 
AST 
(SGOT) Mg 
Treatments g/dl g/dl mg/dl mg/dl mg/dl mg/dl mg/dl mg/dl U/l meq/l 
Pre transport 
0%  5.98 3.15 10.25 6.56 69.36 26.56 0.55 0.25 133.36 2.1 
0.5%  5.89 3.15 10.42 6.35 65.09 24.96 0.56 0.28 103.55 1.99 
1%  5.88 3.14 10.47 6.5 67.82 26.24 0.57 0.26 116.82 2.01 
2%  6.32 3.24 10.75 7.04 69.55 24.05 0.56 0.25 118.73 2.15 
Post transport 
0%  6.04a 3.24ab 11.22az 7.68abz 85.27abz 24.36ab 0.59 0.22 137.27a 2.30abz 
0.5%  6.23bc 3.31 11.33bc 7.21 86.09z 25.15cd 0.61a 0.23 104.45 2.34cdz 
1%  5.56c 2.97a 10.30c 6.46a 80.91az 20.17acz 0.58 0.20z 102.09a 2.05ac 
2%  5.45ab 2.83b 9.84ab 6.63b 74.82b 20.44bdz 0.52a 0.36 103.73 1.95bd 
Means with same superscript within columns and within pre or post transport sampling are different (P < 0.05).   
z Significant change from pre-transport concentrations. 
 
 
 
 Treatments caused no differences in the pre-transport concentrations of Na, K, or 
Cl.  However, the pre-transport Na/K ratio of the sheep fed the 1 and 2% rates of ANOD 
were significantly lower than the control sheep (P = 0.03, 0.06).  There were several 
differences in the post transport electrolyte concentrations where higher supplemented 
sheep had lower electrolyte concentrations than the lower supplemented sheep (Table 7).   
There were several significant changes between pre to post transport electrolyte 
concentrations.  The control sheep significantly increased in sodium, potassium, and 
chloride concentrations post transport (Table 7).  The sheep at the 0.5% rate significantly 
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increased in potassium concentration by the end of transport; otherwise, all other 
treatments showed no significant change in electrolytes as a result of transport. 
 
 
Table 7.  Electrolyte concentrations (meq/l) pre and post transport  
 Treatments Na K Na/K ratio Cl 
Pre transport 
0%  134.73 4.06 33.20a 101.4 
0.5%  131.27 4.11 32.05 99.73 
1%  132.27 4.2 31.60a 100.2 
2%  136.91 4.32 31.79 102.9 
Post transport 
0%  141.45abz 4.79abz 29.67a 107.82abz 
0.5%  141.45cd 4.55z 31.16a 107.91cd 
1%  129.27ac 4.36a 29.8 97.91ac 
2 126.27bd 4.17b 30.32 95.45bd 
Means with same superscript within columns and within pre or post transport sampling are 
different (P < 0.05).  
 z Significant change from pre-transport concentrations. 
 
 
The percentage of body weight lost during transport was significantly more in the 
sheep fed the 1% and 2% rates of ANOD than in the control sheep. 
No differences were seen in latency to eat as all sheep initially went to feed upon 
release into the pen after transport.  There was a trend for a dose dependent effect on 
time to drink, with the control sheep taking the longest and the sheep fed the 2% rate of 
ANOD taking the shortest time to drink after transport (P = 0.20).  Finally, no difference 
was seen in latency to lay after transport as all sheep lay at approximately 1.5h post 
transport.   
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Discussion 
Supplementation did not affect overall growth during the dose response trial, 
contrary to what was reported by Turner et al. (2002) as a result of their 14 d 
supplementation.  Supplementation with ANOD at the 1% rate appeared to increase 
daily gain. However, the higher rates had no effect on average daily gain.  Therefore, it 
is likely that the increased growth at the 1% rate was an aberration, as there was not a 
significant quadratic dose response even during the second week (P > 0.05).   
The ANOD dramatically decreased the antibody titer.  There was a very strong 
dose dependent response which raises concern.  It is important to note that this decreased 
antibody production was not only seen in the post boost response in both IgG and IgM, 
but IgM was already lower in high supplemented animals before the booster.  This is 
indicative of a decreased antibody titer even before the booster, demonstrating a 
suppression of existing antibody titer.  This decreased humoral immune response is 
noteworthy as it has been reported that cellular immune response was increased after 
ANOD supplementation (Allen et al., 2001b; Saker et al., 2001).  It is possible that 
ANOD supplementation is causing one immune system to predominate. 
Although it has been reported that ANOD decreased basal body temperature 
during the summer (Allen et al., 2001b), that effect was not seen in this study in response 
to walking.  Although ANOD helps maintain lower body temperature during hot 
weather, it does not have the same effects during vigorous handling of livestock.  This is 
not unexpected, as the physiology which causes and controls body temperature during 
exercise is different from what occurs in resting animals during ambient heat stress.  
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Exercise causes an increase in body temperature due to energy expenditure from muscle 
movement.  As long as an animal continues to exercise, heat is continually being 
produced internally.   
The ability of ANOD to moderate body temperature was observed during 
transport as the sheep fed the 2% rate had a narrower range in temperature.  The 2% rate 
also caused the sheep at that rate to have lower average and maximum body temperature 
during periods of medium heat stress (THI above 80).  This is consistent with previous 
research in cattle (Allen et al., 2001a,b) that investigated the effects of ANOD on body 
temperature.   
 The ANOD did decrease cortisol plasma concentrations in the higher 
supplemented sheep compared to the control sheep in both the walking and transport 
trials.  It was not clear whether this is due to a decreased perception of stress or a 
decrease in the HPA axis’s function.  Supplementation did not affect the release of 
cortisol in response to walking as the differences before walking were maintained post 
walking.  This indicates that the initial differences between sheep were due to the 
supplementation itself and not the walking.  The control sheep also had significantly 
higher cortisol concentrations than the sheep fed the 2% rate of ANOD during the hottest 
part of transport and cortisol was generally higher in the controls at all times.  This 
indicates that the sheep fed the 2% rate of ANOD were possibly less stressed during 
these periods.   
Supplementation also appeared to affect the regulation of water balance.  Prior to 
transport, the higher supplemented sheep had lower concentrations of aldosterone 
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indicating that they were excreting sodium and retaining potassium (Dickson, 1993) 
before transport began.  Low aldosterone concentration before transport may have 
allowed the supplemented sheep to remain hydrated throughout transport.  Supplemented 
sheep were already excreting sodium, counteracting the increase usually seen in 
electrolyte concentrations due to the water loss from excretion and thermo regulation.  
This hypothesis was supported by the changes in plasma chemistry, as highly 
supplemented sheep also maintained plasma chemistry concentrations during transport.  
Aldosterone concentrations after transport were similar among all treatments, possibly 
indicating that the control sheep were compensating for their altered electrolyte 
concentrations.   
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COMPONENT TRIAL 
Once the appropriate supplementation rate was determined through the dose 
response trial, several major components of the ANOD were evaluated to determine their 
contribution to the treatment effects observed in the dose response trial.  The results of 
the component trial may possibly eliminate the need to feed the ANOD as a whole to get 
beneficial effects.  It might also be possible to determine if a specific component was 
causing the detrimental effects seen in the previous trial. If any negative components 
could be identified, that component could possibly be removed from the seaweed 
supplement.  
 
Methods and materials 
 General.  Fifty-three crossbred sheep averaging 25 kg were used in this study.  
There were nineteen ewes and thirty-four whethers, all of which were immunized in 
each side of their rump with 0.5 mg ovalbumin (egg protein) suspended in 0.25 ml of 
saline and 0.25 ml of Fruend’s incomplete adjuvant three weeks prior (-21 d) to day 0.  
The whethers and ewes where housed in adjacent pastures.  Each sheep was randomly 
assigned to receive ANOD (Tasco 14, Acardian Agritech, Dartmouth, Nova Scotia, 
Canada) at the rate of 0 (control) or 2% of daily dry matter intake as estimated by the 
NRC (1985), or 3 g of fucoidan (PRI, City of Industry, CA), or 1 g of sodium (Na/Cl) 
and 1 g of potassium (potassium glutamate), or 0.25 g of betaine (Betafin, Dansico, 
Copenhagen, Denmark).  The fucoidan, salt, and betaine were fed at a rate to mimic the 
amount consumed within the 2% ANOD treatment.  Twice daily, starting on day 1 and 
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continuing until day 14, the sheep were brought down from the pasture to the working 
pens.  Sheep were each given three boluses (gelatin capsules, size 14, Torpac, NJ, USA )  
containing the appropriate amount of substance based on their treatment.  After receiving 
the boluses, they were released back into the pasture.   
 During the two week ANOD supplementation, the sheep were weighed on day 0 
and day 15 to determine growth rate.  On day 11, all sheep were injected I.M. in each 
side of their rump with 0.5 mg ovalbumin (egg protein) suspended in 0.25 ml of saline to 
test humoral immune response (antibody production) using the same ELISA procedure 
as in the dose response trial.  Blood samples (10 ml) were taken via jugular vena 
puncture on day 11, 15, and 18 to determine antibody production.  The samples on day 
15 also had a CBC with differential count performed by the Texas Veterinary and 
Medical Diagnostic Laboratory, College Station, Tx.   
Transport trial.  All sheep had temperature loggers (Thermochrons, 
Maxim/Dallas Semiconductor Corp., Sunnyvale, CA) placed in one of their ear canals on 
day 15 immediately prior to transport to measure body temperature during transport.  
The procedure for placing the data loggers within the ear was the same as in the dose 
response trial.   Loggers were set to record a temperature every 5 min.   
 Sheep were transported on day 15 over local roads near College Station, Tx for 
eight h (1000-1800h) during the month of September in a goose neck trailer.  Treatments 
were equally divided among seven compartments within the trailer.  Each compartment 
had a similar stocking density.  The external temperature during transport ranged 
between 26.0-33.6 ºC and the temperature inside the trailer ranged between 26.0-34.9 ºC.  
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 Ten ml of blood was taken from all sheep via jugular vena puncture at 0, +4, and 
+8 of transport.  Samples were then frozen until analyzed.  All samples were analyzed 
for cortisol concentration, and the 0 and +8h were analyzed for aldosterone 
concentrations using commercially available RIA kits (DPC, Los Angeles, CA).  Any 
duplicates that differed by more than 12% were re-assayed.  The intra-assay and inter-
assay CV for the cortisol and aldosterone assays were less than 8%.  The ten ml of blood 
that was taken at 0 and +8h of transport was also analyzed for electrolyte concentration 
by the Texas Veterinary and Medical Diagnostic Laboratory, College Station, Tx.  
Weights were taken before and after transport to measure the amount of body 
weight lost during the transport period.  All animals were led onto the scale one by one 
before transport, and the process was repeated after the transport; after transport, sheep 
were not offered feed and water until after they were weighed.   
Following transport, the latency to eat and drink was recorded for all sheep by 
observers.  The sheep were simultaneously released into their home pastures containing 
a feed and a water trough.  The feed trough was the same as the round feeders that the 
sheep fed from daily and the whethers’ pasture was supplemented with two 4 m troughs 
filled with feed (16% pelleted ratio) to allow all sheep room to eat.  A water trough in 
both pastures was equipped with a float valve for automatic refilling.   
 
Statistical analysis.  Humoral immune response and cortisol during transport 
were analyzed following a repeated measures design.  Proc GLM (SAS version 8.2, SAS 
Institute Inc., USA) was used with treatment, time, sex, and the treatment by time 
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interaction, and individual sheep nested within treatment as the factors.  When 
significant treatment by time interactions were found, mean separation was performed 
using the pdiff function.  Average daily gain, body temperature, CBC, electrolyte, 
aldosterone, weight loss, and behavior data were analyzed using ANOVA followed by 
the LSD procedure for post hoc analysis of pair wise comparisons.  Significant 
differences were P < 0.05, unless otherwise stated.   
 
Results 
General.  There was no difference between treatments for growth rates of any of 
the treatments during the 14 d supplementation period.   
 All sheep had similar amounts of IgG specific to ovalbumin on day 11 (Table 8).  
On day 15, the ANOD sheep had a significantly lower IgG titer than the control sheep.  
The salt sheep showed a slight trend for a reduced IgG immune response (P = 0.20) 
relative to the controls.  By day 18, all sheep had similar IgG titers once again (Table 8).  
A similar effect was also seen in the IgM response; the exceptions were seen in the 
betaine sheep starting with lower IgM titer and in the salt sheep ending with higher IgM 
titer than the control sheep on day 18. 
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Table 8. Mean IgG and IgM titers (absorbance at 450 nm ± SE) of sheep during component trial 
  ____________IgG_____________ ____________IgM____________ 
 Treatment Day 11 Day 15 Day 18 Day 11 Day 15 Day 18 
ANOD 0.15 ± 0.05 0.63a ± 0.07 0.69 ± 0.13 1.07a ± 0.03 0.85abc± 0.07 1.48 ± 0.19 
Fucoidan 0.22 ± 0.02 0.70 ± 0.05 0.71 ± 0.10 1.05± 0.02 1.27ad ± 0.04 1.36± 0.08 
Salt 0.19 ± 0.03 0.69 ± 0.04 0.68 ± 0.13 1.19b ± 0.07  0.79def ± 0.08 1.57ab ± 0.11 
Betaine 0.16 ± 0.02 0.70 ± 0.04 0.72 ± 0.07 0.91abc ± 0.08 1.22be ± 0.08 1.27a ± 0.06 
Control 0.20 ± 0.03 0.80a ± 0.08 0.67 ± 0.15 1.19c ± 0.20 1.42cf ± 0.21 1.31b ± 0.12 
Means with same superscript within columns are different (P < 0.05).  
 
  
  
 
 The ANOD sheep tended to have higher (P = 0.10) white blood cell counts, 
eosoniphils (P = 0.10), and lymphocyte counts (P = 0.06) than the control sheep 
following 14 day supplementation (Table 9).  The salt sheep had higher lymphocyte 
counts (P = 0.06) than the controls following supplementation (Table 9).  The betaine 
sheep had higher plasma cell volume and hemoglobin (P = 0.06) than the control sheep 
following supplementation.  There was no difference in neutrophil/lymphocyte ratio 
between any treatments. All other measurements in the complete blood count data 
(Appendix Tables 37-40) were not significantly different from the controls. 
  
 
Table 9. Mean white blood cell count (WBC), packed cell volume (PCV), hemoglobin, eosoniphil, and 
lymphocyte count (± SE) on day 15. 
 Treatment WBC PCV Hemoglobin Eosoniphil Lymphocte 
ANOD 6440a ± 527 27.98 ± 0.87 9.58a ± 0.31 507.7abcd ± 176 3555ab ± 232 
Fucoidan 4982 ± 416 28.61 ± 0.66 9.95 ± 0.23 123.3a ± 170 2581ac ± 214 
Salt 6009 ± 519 28.14 ± 0.75 9.72 ± 0.31 150.9b ± 175 3543cd ± 247 
Betaine 5320 ± 571 29.93a ± 0.79 10.37ab ± 0.30 162.3c ± 89 2891 ± 324 
Control 4964a ± 635 27.47a ± 1.26 9.46b ± 0.46 276.0d ± 58 2486bd ± 328 
Similar superscripts significantly different (P < 0.10). 
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Transport.  During the eight h of transport, all sheep reached similar maximum 
and minimum body temperatures (Table 10).  The temperature range for the ANOD 
sheep tended to be smaller than the control sheep, though they were not significantly 
different.  The THI was above 80 for all of the transport.  The ANOD supplemented 
sheep often maintained a lower body temperature during hot periods of transport than the 
control sheep (Fig. 3).  There was no difference between the variance of body 
temperature during transport (avg 0.34).  The mean number of sheep used to collect 
temperature data was 7.5 ± 1.0 per treatment during transport.  Some sheep lost their 
temperature loggers during transport.  The number of sheep with working loggers did 
not steadily diminish as most loggers were found and replaced in the ear canal midway 
through transport. 
 
 
 
 
 
Table 10.  Ear canal maximum, minimum, and temperature range  (ºC ± SE) during 8h of 
transport 
 Temperature 
Treatment Maximum Minimum Range 
ANOD 38.58 ± 0.12 37.25 ± 0.37 1.19 ± 0.22 
Fucoidan 38.69 ± 0.25 37.06 ± 0.18 1.44 ± 0.20 
Salt 38.77 ± 0.16 36.98 ± 0.24 1.86 ± 0.21 
Betaine 38.76 ± 0.10 37.11 ± 0.30 1.65 ± 0.21 
Control 38.77 ± 0.14 36.91 ± 0.36 1.61 ± 0.23 
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Prior to the start of supplementation (d -21) all sheep had similar cortisol 
concentrations (Figure 4).  At the start of transport the ANOD and salt sheep tended to 
have lower cortisol concentrations than the control sheep (P = 0.08, 0.12).  The salt 
sheep continued to have significantly lower cortisol concentrations than the control 
sheep throughout transport, while the ANOD sheep generally had lower, though non-
significant concentrations (Figure 4).   
 
On day -21 all sheep had similar aldosterone concentrations (Table 11).  Pre-
transport, the ANOD, fucoidan, salt, and betaine sheep all showed a slight trend for 
lower aldosterone concentrations than the control sheep (P = 0.10, 0.07, 0.14, 0.09).  
After transport all sheep had similar concentrations of aldosterone when compared with 
the control sheep (P > 0.05). 
 
Table 11. Aldosterone concentrations (ng/dl) pre and post 12h transport  
Treatment Day -21 Pre transport Post transport 
ANOD 13.39 ± 3.84 5.51 ± 1.19a 5.08 ± 1.26a 
Fucoidan 11.15 ± 1.76 5.19 ± 1.65b 7.85 ± 1.90 
Salt 8.80 ± 1.60 5.97± 1.76  7.31 ± 1.57 
Betaine 9.66 ± 2.06 5.37 ± 1.06c 10.07 ± 2.27a 
Control 12.32 ± 2.33 9.30± 1.98abc 6.83± 1.70  
Means with same superscript within columns are different (P < 0.10). 
 
 
 There were no differences between the control and the other treatments in pre-
transport concentrations of Na, K, Na/K ratio, or Cl (Table 12).  The one exception was 
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with the salt sheep, which had lower pre-transport Na/K ratio and chloride 
concentrations than the control sheep (P = 0.07, 0.01).  There were several differences in 
the post transport electrolyte concentrations, in which control sheep had higher sodium 
and chloride concentrations than other treatments (Table 12).   
All sheep significantly increased in sodium concentrations post transport (Table 
12).  Na/K ratio was impacted by transport in the control and salt sheep but not in the 
other sheep.  All sheep, except for the fucoidan and salt sheep increased in chloride 
concentrations post transport as well.   
 
 
Table 12.  Electrolyte concentrations (meq/l) pre and post transport  
 Treatments Na K Na/K ratio Cl 
Pre transport 
ANOD 144.40 4.62a 31.32a 109.60 
Fucoidan 144.27 4.75 30.42 110.36 
Salt 144.36 4.82 30.04b 108.64a 
Betaine 144.10 4.67a 31.05 109.80 
Control 145.27 4.65 31.29ab 110.64a 
Post transport 
ANOD 148.50abz 4.72 31.50 111.00aez 
Fucoidan 148.09acz 4.64 32.22 111.55be 
Salt 149.73cz 4.63 32.75z 109.18cdef 
Betaine 149.50dz 4.61 32.55 111.70fz 
Control 151.18bdz 4.54 33.63z 113.55abcz 
Means with same superscript within columns and pre and post transport period 
are different (P < 0.10). 
z Significant change from pre-transport concentrations. 
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There was no difference between the control  and any other treatments in the 
percentage of weight lost as a result of transport as all sheep lost between eight and ten 
percent of body weight.   
No differences were seen in latency to eat as all sheep initially proceeded to feed 
upon release into the pen after transport.  Control sheep tended to drink sooner than 
ANOD and fucoidan sheep post transport (P = 0.17, 0.09). 
 
Discussion 
The suppression of humoral immunity (antibody titer) which was seen during the 
dose response trial was also seen in the component trial in the ANOD and salt 
treatments.  While all treatments did not have as high IgG or IgM titers as the controls, 
only the salt sheep and ANOD sheep had a significantly reduced IgM titer on day 15.  
Salt appears to be the component which is contributing to the decreased humoral 
immune response as a result of feeding ANOD.  Excess chloride, twice required levels, 
when sodium is not increased can decrease humoral immunity (Latshaw, 1991).  
Because the salt in the pelleted diet and mineral supplement was in the form of sodium 
chloride, and the drinking water had four times as much sodium as chloride, it is unlikely 
that chloride levels reached the amount needed to suppress humoral immunity.  Further 
research is needed to determine the mechanism of suppression caused by the salt 
supplementation in this study. 
It was reported that ANOD increased cellular immunity in cattle (Allen et al., 
2001b; Saker et al., 2001).  This trial appears to support that assessment as the salt and 
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ANOD sheep in the component trial had higher white blood cell counts and lymphocyte 
counts.  This, coupled with the humoral data, suggests that a component of ANOD is 
causing a switch to a predominately cellular immune response (Abbas et al., 2000).   
Similar body temperature responses were seen in this trial as in the dose response 
trial with the ANOD sheep, though much of the results were non-significant due to lower 
numbers of successfully recorded ear canal temperatures.  The mean number of sheep 
from which viable data could be collected from during this trial was 7.5 ± 1.0 due to 
sheep losing their temperature loggers.  It was also not clear as to which of the studied 
components, if any, could be causing the reduced body temperature as all components 
showed no consistent trend body temperatures in relation to the controls during 
transport. 
   To determine if supplementation was impacting plasma cortisol, we sampled the 
sheep prior to the start of supplementation.  Supplementation with ANOD caused a 
decrease in plasma cortisol concentration.  This was also true for the salt sheep which 
had lower cortisol throughout transport.  This suggests that ANOD, and specifically the 
salt contained within it, are causing a decrease in adrenal function.   
   If the decreased cortisol concentrations are further combined with the lowered 
aldosterone concentrations seen in this trial in the sheep fed the 2% rate of ANOD prior 
to transport, it does appear that the adrenal function might have been affected by the 
ANOD.  If this decreased adrenal function results in insufficiency of adrenal hormones, 
it can lead to chronic fatigue (Siegel and Melby, 1994).  The affect of ANOD on the 
adrenal gland, however, requires further study. 
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While the component trial’s lower aldosterone levels were not as dramatic as in 
the dose response trial, the experimental treatments did have lower sodium and chloride 
concentrations post transport than the control sheep.  This again indicates they were 
better physically hydrated, since their electrolyte balance was maintained.  The betaine 
sheep had higher packed cell volume and hemoglobin, indicating dehydration due to 
water loss.  It is plausible that betaine may cause increased water loss if fed for two 
weeks, though more research is needed to confirm this conclusion.  There is very little 
published data available on the effect of feeding betaine to ruminants.  Betaine also did 
not impact growth as seen in previous studies (Felix and Sudharsan, 2004; Wray et al., 
2004; Wang et al., 2004) and is likely not the component responsible for increased 
growth seen by Turner et al. (2001). 
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GENERAL DISCUSSION 
 All previous studies either sprayed an ANOD extract on the grass the animals 
were grazing, mixed it in the feed (Allen et al., 2001a,b), or fed it as a mineral 
supplement (Allen, personal communication).  In those studies, it was assumed that the 
animals ate ANOD at the 2 % rate; however, there is no way of knowing if these animals 
uniformly consumed the ANOD at the expected rate.  In the current study, sheep were 
given ANOD boluses to guarantee that each one received the specified concentration of 
ANOD.  This enabled a more accurate investigation of the effects of different 
supplementation concentrations than in any previous study. 
 The dose response trial found that ANOD had no effect on the regulation of body 
temperature during exercise.  The supplement also had no impact on average daily gain 
during that trial, contrary to what was seen in Turner et al. (2002).  However, ANOD 
was only fed for two weeks and a longer feeding period may be necessary to influence 
daily gain.  The dose response trial did reveal that ANOD can reduce body temperature 
during transport in conditions where the THI is at least 80.  This trial also confirmed that 
the 2% rate of supplementation suggested in other studies (Allen et al., 2001a,b) is the 
appropriate rate for sheep to get the desired lowering of body temperature.  However, as 
the amount of ANOD was increased, suppression of antibody titer increased in a dose 
dependent manner.  There also appeared to be a greater effect on adrenal hormones as 
the supplementation rate was increased.  Since the 2% rate decreased pre-transport 
aldosterone concentrations, this may have allowed sheep at the 2% rate to maintain 
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electrolyte concentrations during transport as they increased salt excretion through 
urination. 
 This study also sought to determine the active components of ANOD which 
caused the treatment effects seen in the dose response trial.  By giving boluses to the 
sheep with equal proportions of the components as those found within ANOD when fed 
at 2% of DMI, we were able to determine if those components were responsible for the 
effects on body temperature, immune function, adrenal hormones, and hydration that 
were found in the dose response trial.   
   The ANOD treatment in the component trial again indicated lowered body 
temperature and a suppressed humoral immune response.  The ANOD also appeared to 
increase cellular immunity as suggested by Allen et al. (2001b) and Saker et al. (2001).  
There was an increase in total WBC number and specifically lymphocytes.  Though it 
needs confirmation, one can infer that the increase in lymphocytes indicated an increase 
in T cells.  If B cells increased instead of T cells, humoral immune response would not 
have been suppressed.  This trial also confirmed that the supplementation of ANOD 
caused a reduction in adrenal function, as prior to supplementation all sheep had similar 
cortisol and aldosterone concentrations.   
Of the components studied, only the salt seemed to be causing the effects on 
immunity and adrenal function demonstrated by ANOD supplementation.  The salt 
affected humoral and cellular immunity, and adrenal function in a similar manner as the 
ANOD.  After supplementation, betaine sheep showed higher PCV and lower 
aldosterone concentrations than the control sheep.  This indicates that betaine sheep were 
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less hydrated than controls, which differs from previous research which found that 
betaine helped to retain water (Partridge, 2003).   Since such a small amount of betaine 
was fed, it is possible that it was not enough to see the positive effects seen in other 
studies.  Belay et al. (1992), fed betaine at a rate of 0.10% of total feed intake.  In this 
study, however, betaine was fed at a substantially lower rate.  Fucoidan caused similar 
affects compared to those seen in the dose response trial on post supplementation 
aldosterone concentrations and electrolyte concentration maintenance.  Although 
previous research (Maruyama et al., 2003; Tissot et al., 2003; Chotigeat et al., 2004; 
Eiwegger et al., 2004; Lee et al., 2004) found that fucoidan affected immune function, it 
had no effect in this study.   
The reduced antibody titers observed in both trials is troubling as it leaves 
supplemented animals open to bacterial infections.  Without antibodies to respond to a 
bacterial infection, bacteria will likely prosper in an ANOD supplemented animal, 
though more research is needed to confirm it. Antibodies produced during a humoral 
immune response are needed to neutralize bacteria by binding to them, to opsinize 
bacteria to promote phagocytosis, to aid natural killer cells in their ability to lyse 
bacteria, and to activate the compliment system (Abbas et al., 2000).  It is also important 
to note that it would be counterproductive to vaccinate animals who are being 
supplemented with ANOD as they would produce little to no antibodies.  Vaccinating 
prior to supplementation with ANOD may be advisable, though suppression of all 
antibodies is likely no matter when vaccination occurs.  Recent research has shown that 
ANOD supplementation can reduce the amount of E. coli found in feces and on the 
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bodies of cattle (Braden et al., 2004).  The reduction in E. coli, however, is likely not 
occurring as a result of the humoral immune system as other studies have not shown the 
impact of feeding ANOD on bacterial infections (Allen et al., 2001b).  It is likely some 
change in intestinal pH or other mechanism is the reason for the decreased E. coli 
numbers and anti bacterial effects of ANOD (Vacca and Walsh, 1954) though research is 
needed to confirm this. 
  The trend for lower body temperature in the supplemented sheep in both trials could 
have resulted in a reduced loss of water through thermo regulation as the need to cool 
their bodies was decreased.  Water loss through excretion was likely higher during the 
dose response trial than in the component trial because the average percentage of weight 
loss during transport were 12.4% and 8.9%, respectively.  Weight loss as a result of 
transport is due mostly to water loss.  In the dose response trial, the higher supplemented 
sheep lost more weight than the control sheep, while in the component trial all sheep lost 
similar amounts.  The difference between the trials is likely due to the greater difference 
in aldosterone concentrations in the dose response trial compared to the component trial.   
During the dose response trial the higher supplemented sheep were excreting more salt 
via urination than the control sheep based on their aldosterone concentrations.  The 
aldosterone concentrations of the treatments in the component trial were more similar to 
each other, indicating they were likely urinating similar amounts (Borresen et al., 1982; 
Dick et al., 1994).  Urine volume was not measured in this study, but should be 
quantified in future studies.  The pattern for which treatment drank first after transport 
was not consistent.  Highly supplemented sheep in the dose response trial were possibly 
                                                                                                                                             70
urinating more which accounted for their increased body weight loss and increased 
thirst.  The ANOD supplemented sheep had lower plasma electrolytes post transport than 
the control sheep in both trials, although it was more noticeable in the dose response 
trial.  Because the ANOD supplemented sheep had less concentrated electrolytes in their 
blood, water with electrolytes will be most useful in rehydrating those sheep.  Water 
without electrolytes could be detrimental as it would further decrease the concentration 
of electrolytes within their plasma.  Sex of the animals did not have an effect in any 
treatment in either trial. 
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CONCLUSION 
 
 Livestock are often transported long distances in hot weather.  This common 
practice has led to the need to find methods of decreasing the effects of transport and 
heat stress on these animals.  One possible option is to find dietary supplements that 
could alleviate some of the stress.  The seaweed ANOD has shown numerous beneficial 
results that could make it useful in the alleviation of stress associated with handling and 
transport of livestock.  An extract of the ANOD has been reported to lower core body 
temperature of cattle in hot weather while also stimulating a higher core body 
temperature in cold weather (Allen et al., 2001a,b), increase cell mediated immune 
function (Allen et al., 2001b; Saker et al., 2001), increase weight gain (Turner et al., 
2002), increase marbling (Allen et al., 2001a), increase shelf life of meat (Montgomery 
et al., 2001), and has anti-bacterial characteristics (Allen et al., 2001b).  All of these 
would likely improve the well being and production of livestock. 
 In this study, ANOD showed some positive effects in the alleviation of heat 
stress during transport, but it also had a significant negative impact.  The 14 d 
supplementation of ANOD at the 2% rate lowered body temperature during 
transportation and maintained electrolyte and plasma chemistry throughout transport.  
However, the humoral immune system was negatively affected by supplementation with 
ANOD.  It appears that salt is the component of ANOD which caused the reduced 
antibody titers.  It is still unclear which component of ANOD is causing the decrease in 
body temperature as none of the tested components caused similar effects as the ANOD.  
Supplementation also lowered cortisol and aldosterone concentrations, indicating a 
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possible decrease in adrenal function.  This suppressive effect that ANOD appears to 
have on the adrenal gland is troubling as proper functioning of the adrenal is needed to 
maintain the bodies homeostasis and for the stress response (Swenson, 1993); however, 
future trials are needed to ascertain whether the decreased cortisol and aldosterone 
concentrations are truly detrimental.  Although ANOD showed promise in dealing with 
heat stress during transport, its negative effects on antibody production may outweigh 
the positive effects.  If animals have no defense against bacterial infections, such as 
those affecting the respiratory system, they will likely become ill.  This makes the 
supplementation of livestock with ANOD unadvisable until further research can confirm 
that the health of supplemented animals is not at risk and until the mechanism by which 
ANOD is affecting antibody production is determined. 
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APPENDIX 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 13.  Group number and corresponding treatment 
Trial 
Treatment 
# Ttreatment 
1 1 0% (control) 
1 2 0.5%  
1 3 1%  
1 4 2%  
2 1 2%  
2 2 fucoidan  
2 3 salt  
2 4 betaine  
2 5 0%  (control) 
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Table 14.  Weights of sheep collected during the dose response trial (kg) 
Treatment 
# Sex Sheep # Wt 1 Wt 2  Wt 3  Wt 4  Wt 5  Wt 6  Wt 7 
              pre-transport post transport   
1 F 1 22 24 26 27 29 25 29 
1 F 10 27 31 33 34 34 29 34 
1 F 11 27 30 32 34 35 31 35 
1 F 12 27 28 30 29 29 25 30 
1 F 13 23 24 27 29 26 24 29 
1 M 14 37 39 41 44 43 39 43 
1 M 15 23 26 28 29 30 26 31 
1 M 16 24 25 31 32 31 28 34 
1 M 17 30 32 36 37 37 33 38 
1 M 18 33 35 37 38 39 35 40 
1 M 19 27 29 32 33 34 30 34 
                    
2 F 2 23 24 27 26 28 23 27 
2 F 20 27 27 31 31 33 29 34 
2 M 21 33 35 39 39 40 36 39 
2 M 22 27 29 33 35 34 30 35 
2 F 23 26 26 26 29 30 27 30 
2 F 24 27 25 26 27 29 24 29 
2 F 25 22 23 24 25 26 23 26 
2 F 26 28 29 32 34 32 29 35 
2 M 27 17 18 21 21 22 19 24 
2 M 28 28 28 30 33 34 29 34 
2 M 29 27 29 29 33 35 31 34 
                    
3 F 3 24 24 28 30 29 25 30 
3 F 30 22 23 26 27 27 24 28 
3 F 31 21 22 24 26 26 23 27 
3 M 32 34 35 36 39 38 34 39 
3 M 33 34 35 36 39 39 34 40 
3 M 34 33 36 36 38 39 34 39 
3 F 35 27 30 32 34 34 30 34 
3 M 36 23 25 29 31 32 27 32 
3 M 37 26 27 30 33 33 29 32 
3 F 38 26 28 30 33 34 29 34 
3 F 39 26 28 33 34 35 30 35 
                    
4 M 4 20 23 22 26 27 24 28 
4 F 40 24 24 29 29 28 24 29 
4 F 41 26 28 30 32 32 28 31 
4 M 42 34 33 34 34 38 34 39 
4 M 43 27 29 32 34 36 30 35 
4 F 44 27 27 29 32 32 27 32 
4 M 45 18 19 21 24 24 20 24 
4 F 46 26 29 31 32 31 27 33 
4 F 47 26 28 30 31 30 27 32 
4 M 48 31 32 32 36 38 33 37 
4 F 49 25 24 28 30 29 26 30 
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Table 15. Cortisol concentrations (ug/dl) collected during the dose response trial 
Sheep # Basal Pre-walk Post-walk Pre-transport 4h transport 8h transport 12h trans 2d post-trans 
1 1.41 2.65 0.83 2.39 0.79 0.52 0.62 0.94 
10 2.38 4.32 1.06 1.41 1.11 0.87 0.43 0.66 
11 1.11 0.79 1.33 0.50 0.92 1.72 1.05 0.87 
12 1.31 1.75 3.21 1.70 0.81 1.53 0.65 0.56 
13 1.41 3.63 0.55 0.42 0.85 1.18 0.85 0.49 
14 1.25 0.35 0.79 0.47 0.84 0.93 0.66 0.82 
15 2.50 1.74 2.99 0.91 0.81 1.84 1.22 1.45 
16 1.31 1.68 0.64 0.92 0.61 1.72 1.77 0.61 
17 1.78 0.47 1.10 0.90 1.30 1.01 0.77 0.88 
18 2.64 0.42 0.44 0.98 0.93 1.29 1.00 0.49 
19 2.23 3.11 1.31 1.33 1.00 0.98 0.76 0.83 
2 0.60 1.21 2.49 0.80 0.76 1.01 0.39 0.12 
20 1.70 0.80 1.54 0.84 0.78 0.85 0.83 0.55 
21 0.67 1.27 2.61 0.63 0.62 0.73 1.16 0.60 
22 1.35 1.08 1.27 0.98 0.68 0.95 0.45 0.50 
23 0.92 0.78 0.66 0.59 0.80 0.16 0.75 0.39 
24 2.23 1.03 2.85 0.55 0.70 0.88 0.50 0.45 
25 0.96 1.23 0.88 0.88 0.88 1.03 0.93 0.97 
26 1.18 3.78 0.86 1.16 0.95 0.79 0.56 0.95 
27 2.00 0.82 1.89 0.75 0.82 0.80 0.43 0.54 
28 1.09 1.76 0.57 0.68 0.48 2.28 0.47 0.57 
29 0.74 0.74 1.37 0.61 0.71 1.08 1.56 0.67 
3 1.22 1.56 1.39 0.70 1.03 2.62 0.86 0.74 
30 1.95 0.99 0.70 0.72 0.55 0.93 1.75 0.63 
31 1.32 1.26 1.86 0.81 0.60 0.93 0.54 0.40 
32 0.80 0.90 1.09 0.32 0.77 0.99 0.40 0.24 
33 1.30 0.59 0.46 0.68 0.88 1.20 0.38 0.25 
34 0.92 0.98 0.32 0.55 0.89 0.78 0.74 0.35 
35 0.82 1.02 0.34 0.52 0.82 0.25 1.03 0.25 
36 0.85 0.90 0.51 0.29 0.67 0.79 0.66 0.28 
37 0.51 0.93 0.70 0.16 0.61 0.35 0.50 0.32 
38 0.63 3.19 0.89 0.75 1.42 0.77 0.67 0.44 
39 0.49 1.48 1.33 0.85 0.62 0.97 0.55 0.24 
4 0.59 0.41 0.99 0.26 0.61 1.06 0.48 0.84 
40 0.65 1.48 1.20 0.69 0.68 0.91 0.56 0.58 
41 1.96 0.88 1.74 0.70 0.74 0.47 1.14 0.89 
42 2.37 1.13 1.54 0.59 0.12 0.89 0.61 0.49 
43 0.42 0.85 0.68 0.52 0.67 0.88 0.62 0.49 
44 2.91 1.12 0.82 0.27 0.74 1.05 0.98 0.41 
45 1.15 0.53 0.54 0.81 0.32 0.76 1.13 0.54 
46 2.24 0.89 0.54 3.20 1.46 1.57 0.86 0.37 
47 0.54 0.99 0.21 1.26 0.12 0.73 1.00 0.47 
48 1.03 0.82 0.21 0.94 0.64 0.73 0.34 0.53 
49 1.22 1.55 0.62 0.71 0.64 0.84 0.71 0.48 
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Table 16. Aldosterone concentrations (ng/dl) collected during the dose response trial 
Treatment # Sheep # Pre-transport Post-transport 
1 1 42.36 23.80 
1 10 17.71 9.76 
1 11 4.55 21.71 
1 12 65.84 17.86 
1 13 61.01 17.77 
1 14 19.01 13.56 
1 15 25.84 7.54 
1 16 21.21 16.87 
1 17 48.67 19.35 
1 18 27.15 14.01 
1 19 55.41 14.69 
2 2 39.65 29.29 
2 20 15.47 8.70 
2 21 11.63 12.29 
2 22 22.63 8.34 
2 23 24.47 12.99 
2 24 50.88 22.28 
2 25 38.29 26.94 
2 26 24.18 13.61 
2 27 55.54 13.87 
2 28 15.71 12.89 
2 29 55.05 11.51 
3 3 49.64 16.78 
3 30 17.93 33.61 
3 31 29.98 22.08 
3 32 22.38 26.10 
3 33 29.87 21.16 
3 34 15.27 36.92 
3 35 10.07 29.71 
3 36 12.22 21.65 
3 37 14.62 28.85 
3 38 23.05 17.94 
3 39 22.50 17.50 
4 4 19.52 16.01 
4 40 18.94 25.21 
4 41 18.84 8.73 
4 42 12.22 16.22 
4 43 22.45 8.39 
4 44 29.85 11.57 
4 45 24.58 13.41 
4 46 10.67 27.55 
4 47 8.87 15.86 
4 48 26.08 32.05 
4 49 49.87 25.97 
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Table 17.  IgG and IgM titers (abs 450nm) collected during the dose response trial 
Sheep # IgG d 11 IgG d 15 IgG d 18 IgM d 11 IgM d 15 IgM d 18 
1 0.15 0.44 0.88 1.06 1.38 1.57 
10 0.68 3.32 1.97 1.06 1.01 1.27 
11 1.17 2.85 1.30 1.14 0.98 1.44 
12 0.74 2.80 0.86 1.14 1.49 1.48 
13 0.39 3.50 2.10 1.11 0.80 1.19 
14 0.26 0.82 1.46 1.06 1.33 1.72 
15 0.15 4.16 2.15 1.09 1.25 1.11 
16 0.12 0.45 0.17 1.14 1.94 1.32 
17 0.24 0.99 1.43 1.68 1.20 1.12 
18 0.40 4.33 3.06 1.14 1.16 1.15 
19 0.43 2.63 2.42 1.17 1.05 1.27 
2 0.30 1.29 1.75 1.09 1.36 1.31 
20 1.27 5.13 3.60 1.44 1.41 1.69 
21 0.86 2.76 2.57 1.46 0.85 1.22 
22 0.52 0.43 0.17 1.12 1.29 1.05 
23 0.27 0.58 0.63 1.32 1.07 1.25 
24 0.92 1.37 1.53 1.01 0.44 1.22 
25 0.77 0.08 0.82 1.09 0.56 1.48 
26 0.62 0.33 0.82 1.13 0.62 1.71 
27 0.23 1.02 1.53 1.05 0.64 1.45 
28 0.26 0.48 0.95 1.73 0.47 1.36 
29 0.17 0.21 0.71 1.48 0.37 1.02 
3 0.08 1.82 1.78 1.21 0.44 1.25 
30 0.51 0.16 0.31 1.27 0.59 2.11 
31 0.52 0.75 1.55 1.10 0.92 0.69 
32 0.86 1.52 2.05 1.12 0.72 1.12 
33 1.08 1.33 0.68 1.13 0.77 0.68 
34 0.98 0.10 0.94 1.06 0.90 0.78 
35 0.94 1.16 1.37 1.02 0.89 0.67 
36 0.50 0.20 0.19 0.95 0.91 0.72 
37 0.10 1.10 0.33 0.84 0.95 0.82 
38 0.14 1.35 1.99 0.85 1.25 0.67 
39 0.21 0.06 0.80 0.89 0.81 1.60 
4 0.50 0.32 1.04 0.97 1.33 2.02 
40 0.83 0.06 0.78 0.87 1.02 1.55 
41 0.49 0.24 1.15 0.64 0.83 1.12 
42 0.53 0.28 1.25 0.81 0.80 1.13 
43 0.45 0.11 0.33 0.71 0.55 1.26 
44 0.32 0.27 0.93 0.73 0.60 1.17 
45 0.30 0.15 0.26 0.72 0.65 1.35 
46 0.10 0.10 0.05 1.42 0.43 0.23 
47 0.19 0.07 0.22 1.18 0.49 0.41 
48 0.26 0.07 0.41 0.96 0.40 0.32 
49 0.19 0.16 0.43 1.03 0.52 0.43 
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Table 18.  Behavior data (latency min) collected during the dose response trial 
Sheep # Lying  Drinking  Eating 
1 5700 0.25 6.53 
10 5700 0.25 10.93 
11 5700 0.25 14.47 
12 5700 0.25 19.15 
13 5700 0.25 10.23 
14 5379 0.25 13.23 
15 5700 0.25 15.80 
16 5700 0.25 12.80 
17 5700 0.25 25.88 
18 5700 0.25 4.77 
19 4174 0.25 17.05 
2 5220 0.25 5.35 
20 5700 0.25 16.42 
21 5700 0.25 23.68 
22 5700 0.25 9.78 
23 5700 0.25 10.30 
24 5700 0.25 18.93 
25 5210 0.25 10.10 
26 5700 0.25 1.50 
27 5700 0.25 23.97 
28 5700 0.25 0.50 
29 5700 0.25 16.42 
3 4871 0.25 18.53 
30 5700 1.25 0.23 
31 5478 0.25 14.15 
32 5700 0.25 0.65 
33 5700 0.25 10.33 
34 5700 0.25 9.97 
35 5700 0.25 2.25 
36 5700 0.25 15.27 
37 5700 0.25 15.80 
38 4491 0.25 0.47 
39 5700 0.25 21.37 
4 5528 0.25 17.05 
40 5700 0.25 2.00 
41 5700 0.25 2.00 
42 5700 0.25 7.00 
43 5483 0.25 8.57 
44 5700 0.25 15.80 
45 4140 0.25 21.83 
46 5700 0.25 7.33 
47 5700 0.25 10.40 
48 5700 0.25 1.83 
49 5700 0.25 14.20 
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Table 19. Temperature collected during walking (w) and transport  (t) during the dose response trial (˚C) 
 # Rectal Max (t) Min (t) Range (t) Max (w) Min (w) Range (w) Basal 
1 40.78 38.39 36.89 1.50 38.78 38.00 0.78 38.33 
10 41.83 38.50 37.61 0.89 39.28 38.78 0.50 38.83 
11 41.39 38.22 37.11 1.11 38.89 37.94 0.94 38.20 
12 40.78        
13 40.61 38.00 36.28 1.72 38.11 38.11 0.00 38.16 
14 41.33 38.50 37.39 1.11 39.28 38.61 0.67 39.10 
15 41.56 38.89 37.61 1.28 39.28 38.89 0.39 38.80 
16 40.78 38.50 37.22 1.28 38.39 38.00 0.39 38.37 
17 41.22    38.39 37.89 0.50 38.09 
18 41.56 38.78 37.11 1.67 39.11 38.78 0.33 38.92 
19 41.17 38.50 37.50 1.00 38.61 38.22 0.39 38.85 
2 41.44 38.50 37.00 1.50 38.78 38.39 0.39 38.53 
20 40.33 38.89 37.89 1.00 38.78 38.39 0.39 38.73 
21 41.11 38.89 37.61 1.28 38.89 38.89 0.00 39.03 
22 40.94 38.89 38.00 0.89 39.28 38.89 0.39 39.16 
23 41.17 38.00 36.39 1.61 38.22 37.78 0.44 37.90 
24 41.28 38.11 37.11 1.00 38.61 38.39 0.22 38.11 
25 41.22 38.89 37.50 1.39 38.89 38.50 0.39 38.88 
26 41.72 38.50 36.78 1.72 39.11 38.39 0.72 38.81 
27 41.22 38.11 37.22 0.89 38.50 38.00 0.50 38.08 
28 41.39 38.89 38.39 0.50 39.11 39.00 0.11 38.73 
29 41.11 38.61 37.11 1.50 39.11 38.61 0.50 38.61 
3 40.78 37.78 37.00 0.78 38.61 38.11 0.50 38.04 
30 41.39 38.11 36.11 2.00 38.39 37.78 0.61 38.23 
31 41.39 38.00 36.50 1.50 38.00 37.78 0.22 38.15 
32 40.89 38.61 37.50 1.11 39.11 38.50 0.61 38.84 
33 40.89 38.89 37.00 1.89 39.28 39.28 0.00 38.93 
34 41.56 38.39 38.00 0.39 40.00 38.50 1.50 38.58 
35 41.17 38.22 36.11 2.11 38.61 38.39 0.22 38.67 
36 41.39 38.78 37.78 1.00 39.00 38.89 0.11 38.99 
37 41.89 39.11 37.78 1.33 39.39 38.61 0.78 39.05 
38 41.22 38.39 37.78 0.61 39.00 38.39 0.61 38.68 
39 41.06        
4 41.50 37.78 37.22 0.56 38.39 37.78 0.61 38.20 
40 40.83 38.22 37.39 0.83 38.78 38.11 0.67 38.75 
41 40.83 38.11 37.22 0.89 38.39 37.89 0.50 38.14 
42 41.11 38.22 37.00 1.22 38.50 38.22 0.28 38.43 
43 41.11 38.39 37.50 0.89 38.78 38.22 0.56 38.49 
44 40.83 38.50 37.61 0.89 38.50 38.22 0.28 38.36 
45 41.67 38.39 37.11 1.28 38.22 38.50 -0.28 38.41 
46 41.33 38.11 37.39 0.72 38.89 38.50 0.39 38.43 
47 41.28  37.89 1.39 39.50 39.11 0.39 39.34 
48 40.89 38.00 37.39 0.61 38.78 38.50 0.28 38.40 
49 41.39 37.78 36.89 0.89 38.89 38.50 0.39 38.30 
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Table 20. Pre-transport plasma chemistry data collected during the dose response trial: part one 
# P. protein (g/dl) Album. (g/dl) C (mg/dl) P (mg/dl) Glucose (mg/dl) 
1 5.2 2.8 10.1 7.2 72 
10 5.6 2.8 8.9 6.8 63 
11 6.3 3.4 10.7 7.3 64 
12 6.2 3.5 10.5 6.9 74 
13 6.4 3.4 10.2 8.1 61 
14 6.7 3 10.9 5.8 97 
15 5.9 3.1 9.8 8.2 67 
16 6.1 3.3 10.9 5.9 61 
17 5.6 3.1 10.9 5.7 68 
18 6.4 3.2 10.6 6 67 
19 5.4 3 9.3 4.3 69 
2 6.5 3.2 10.8 7.3 74 
20 5.9 3.2 10.4 5 74 
21 5.8 3.1 10.9 6.7 67 
22 6.5 3.5 10.8 7.2 71 
23 5.8 3.3 10.4 5.2 65 
24 6.1 3.2 11.1 6 67 
25 3 1.4 4.4 3.3 28 
26 6.4 3.1 11.4 8 71 
27 6 3.4 10.8 8.6 47 
28 6.7 3.7 12 6.8 70 
29 6.1 3.5 11.6 5.8 82 
3 6.9 3.5 11.1 8.3 62 
30 3.1 1.5 5 4 31 
31 6 3.1 11 8.7 73 
32 5.6 3.1 10.3 5.9 74 
33 6.3 3.4 10.8 6 72 
34 6.5 3.6 12.6 5.1 81 
35 5.6 2.7 9.4 6 54 
36 6.3 3.5 11.8 8.4 83 
37 6.3 3.4 11.4 6.4 66 
38 6.1 3.3 11.1 5.4 76 
39 6 3.4 10.7 7.3 74 
4 6.7 3.1 10.9 7.2 57 
40 3.2 1.7 5.8 3.4 38 
41 6 3.2 11.4 6.3 77 
42 6.8 3.7 12.1 7.7 86 
43 6.5 3.6 11.5 6.4 78 
44 6.5 3.2 10.6 7.4 80 
45 7.8 3.2 11.2 7.4 64 
46 6.4 3.3 10.8 7.2 68 
47 7 3.7 12 8.5 70 
48 6.9 3.7 11.7 8.8 64 
49 5.7 3.2 10.2 7.1 83 
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Table 21. Pre-transport plasma chemistry data collected during the dose response trial: part two 
# BUN (mg/dl) Creat. (mg/dl) T. bilirubin (mg/dl) CK (U/l) Ast(sgot) (U/l) 
1 23.3 0.4 0.2 168 249 
10 22.5 0.5 0.2 66 113 
11 30.3 0.8 0.3 79 129 
12 27.7 0.7 0.2 61 123 
13 30.8 0.6 0.2 207 123 
14 22 0.5 0.2 86 113 
15 33 0.5 0.3 92 141 
16 26.7 0.4 0.3 85 106 
17 25.6 0.5 0.3 82 95 
18 29 0.5 0.2 92 147 
19 21.3 0.7 0.3 64 128 
2 17.4 0.6 0.3 99 121 
20 21.6 0.5 0.3 67 99 
21 27.2 0.7 0.3 63 79 
22 26.8 0.7 0.3 97 83 
23 28 0.6 0.4 117 74 
24 28.8 0.5 0.3 124 114 
25 9 0.2 0.1 42 59 
26 24.1 0.5 0.2 75 165 
27 27.6 0.5 0.4 88 120 
28 33.5 0.8 0.2 81 145 
29 30.6 0.6 0.3 120 80 
3 29.2 0.6 0.3 115 136 
30 15.8 0.3 0.2 50 41 
31 30.2 0.5 0.2 113 153 
32 22.2 0.6 0.3 91 103 
33 30 0.7 0.3 290 134 
34 32.3 0.8 0.3 93 187 
35 23.7 0.5 0.3 65 138 
36 26 0.5 0.2 290 120 
37 25.9 0.5 0.3 133 105 
38 24.4 0.6 0.2 90 74 
39 28.9 0.7 0.3 112 94 
4 23.5 0.5 0.3 114 89 
40 15.4 0.3 0.2 77 63 
41 26.1 0.6 0.3 53 84 
42 25.8 0.6 0.2 114 125 
43 23.4 0.6 0.2 101 87 
44 25.1 0.6 0.3 110 127 
45 20.7 0.5 0.2 76 89 
46 30.2 0.7 0.4 596 118 
47 23.9 0.5 0.3 980 231 
48 28.6 0.8 0.2 271 111 
49 21.9 0.5 0.2 76 182 
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Table 22. Pre-transport plasma chemistry data collected during the dose response trial: part three 
# Globulins (g/dl) A/G ratio GGT (U/l) Mg (meq/l) 
1 2.4 1.17 90 2.2 
10 2.8 1 81 1.8 
11 2.9 1.17 103 2.5 
12 2.7 1.3 89 2.3 
13 3 1.13 97 2 
14 2.9 1.31 66 2.2 
15 2.8 1.11 94 2 
16 2.8 1.18 90 1.8 
17 2.5 1.24 82 2.2 
18 3.2 1 142 2.1 
19 2.4 1.25 74 2 
2 3.3 0.97 101 2 
20 2.7 1.19 86 2 
21 2.7 1.15 132 2.2 
22 3 1.17 68 2.3 
23 2.5 1.32 63 1.7 
24 2.9 1.1 85 2.1 
25 1.6 0.88 48 0.7 
26 3.3 0.94 100 2.1 
27 2.6 1.31 4 2 
28 3 1.23 93 2.5 
29 2.6 1.35 54 2.3 
3 3.4 1.03 102 2.3 
30 1.6 0.94 42 0.9 
31 2.9 1.07 85 2.4 
32 2.5 1.24 68 2.1 
33 2.9 1.17 119 2.1 
34 2.9 1.24 171 2.4 
35 2.9 0.93 106 1.7 
36 2.8 1.25 68 2 
37 2.9 1.17 81 2.1 
38 2.8 1.18 47 2 
39 2.6 1.31 70 2.1 
4 3.6 0.86 71 2.2 
40 1.5 1.13 59 1.1 
41 2.8 1.14 95 2.1 
42 3.1 1.19 77 2.3 
43 2.9 1.24 78 2.3 
44 3.3 0.97 84 2.5 
45 4.6 0.7 161 2.2 
46 3.1 1.06 99 2.4 
47 3.3 1.12 182 2.2 
48 3.2 1.16 99 2.5 
49 2.5 1.28 121 1.8 
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Table 23. Pre-transport electrolytes data collected during the dose response trial 
# Na (meq/l) K (meq/l) Na/K ratio Cl (meq/l) 
1 135 4.1 32.9 102 
10 127 3.7 34.3 93 
11 141 4.4 32 105 
12 142 4.3 33 106 
13 138 4.2 32.9 104 
14 139 4.3 32.3 101 
15 133 4 33.3 100 
16 129 4.1 31.5 97 
17 136 3.9 34.9 105 
18 132 4 33 101 
19 130 3.7 35.1 101 
2 136 4.3 31.6 102 
20 137 4.5 30.4 106 
21 136 4.1 33.2 103 
22 139 4.4 31.6 104 
23 135 3.7 36.5 104 
24 134 4.3 31.2 104 
25 75 2.4 31.2 57 
26 140 4 35 107 
27 140 4.3 32.6 104 
28 133 4.5 29.6 100 
29 139 4.7 29.6 106 
3 142 4.4 32.3 109 
30 84 2.7 31.1 63 
31 137 4.9 28 104 
32 135 3.9 34.6 103 
33 141 4.3 32.8 108 
34 141 4.3 32.8 107 
35 121 3.9 31 92 
36 142 4.8 29.6 106 
37 136 4 34 103 
38 137 4.6 29.8 103 
39 139 4.4 31.6 104 
4 138 4.5 30.7 105 
40 92 2.8 32.9 70 
41 144 4.3 33.5 109 
42 143 4.5 31.8 105 
43 140 4.4 31.8 107 
44 140 4.4 31.8 106 
45 140 4.6 30.4 103 
46 142 4.3 33 107 
47 145 4.9 29.6 108 
48 144 4.6 31.3 107 
49 138 4.2 32.9 105 
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Table 24. Post-transport plasma chemistry data collected during the dose response trial: part one 
# P. protein (g/dl) Album. (g/dl) C. (mg/dl) P (mg/dl) Glucose (mg/dl) 
1 5.7 3.1 12.4 10 101 
10 6.2 3 10.2 7.8 86 
11 5.7 3.1 11.7 7.3 85 
12 6.3 3.4 11.3 8.2 92 
13 6.3 3.3 11.2 7.7 75 
14 6.3 3.7 11.4 8.1 85 
15 5.1 2.7 9.6 7.2 79 
16 6.2 3.4 11.4 7 79 
17 5.7 3.2 11.9 7.6 85 
18 6.8 3.3 11.5 6.6 85 
19 6.2 3.4 10.8 7 86 
2 6 3 11.1 6.2 86 
20 5.6 3 11.2 6.3 92 
21 6.2 3.2 11.1 7.7 85 
22 6.6 3.5 11.2 7.3 82 
23 6.2 3.6 11.8 8.1 92 
24 6 3.3 11.5 6.5 84 
25 6.4 3.1 10.2 7.9 76 
26 6.5 3.1 10.9 7.7 95 
27 6.2 3.4 11.2 7.4 84 
28 6.8 3.7 12.5 7.1 85 
29 6 3.5 11.9 7.1 86 
3 5.4 2.7 9.1 7.3 74 
30 6.1 3.1 10.6 7.2 87 
31 4.9 2.5 9.2 6.8 81 
32 5.8 3.2 11.3 7.4 95 
33 5.7 3.1 10.3 5.8 82 
34 3.9 2.2 7.8 4 57 
35 5.5 2.7 10 6.9 75 
36 6.2 3.5 11.9 8 87 
37 6.5 3.5 12.7 6.6 87 
38 6.2 3.3 11.2 5.5 90 
39 5 2.9 9.2 5.6 75 
4 4.2 2 7.5 5.2 55 
40 5.5 2.9 10.5 6.5 85 
41 4.7 2.5 9.5 6.4 75 
42 6.4 3.5 11.6 6.8 90 
43 3.9 2.2 7.4 4.4 56 
44 5.7 2.8 9.8 8.3 84 
45 7.2 2.9 10.9 8.3 72 
46 5.3 2.9 10 7 72 
47 5.9 3.3 10.8 6.6 78 
48 5.9 3.2 10.4 7.2 78 
49 5.2 2.9 9.8 6.2 78 
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Table 25. Post-transport plasma chemistry data collected during the dose response trial: part two 
# BUN (mg/dl) Creat. (mg/dl) T. bilirubin (mg/dl) CK (U/l) Ast(sgot) (U/l) 
1 22.7 0.5 0.2 348 287 
10 21.2 0.6 0.2 76 112 
11 27.9 0.7 0.2 80 120 
12 22.8 0.7 0.2 91 129 
13 25.5 0.7 0.2 279 125 
14 21.5 0.6 0.2 107 111 
15 25.9 0.5 0.2 79 121 
16 25 0.4 0.3 96 110 
17 24 0.5 0.2 221 100 
18 28.3 0.6 0.2 74 148 
19 23.2 0.7 0.3 280 147 
2 14.9 0.5 0.3 95 106 
20 24.8 0.5 0.2 68 94 
21 30.1 0.7 0.2 65 82 
22 28.1 0.7 0.2 85 83 
23 24.5 0.7 0.3 92 72 
24 27.2 0.6 0.2 108 114 
25 22.1 0.6 0.2 81 125 
26 21 0.6 0.3 85 133 
27 24.1 0.5 0.2 104 122 
28 31.1 0.7 0.2 78 143 
29 28.7 0.6 0.2 63 75 
3 20.6 0.5 0.2 92 103 
30 20.7 0.7 0.2 95 73 
31 21.7 0.5 0.2 87 117 
32 21.1 0.7 0.2 249 107 
33 24.7 0.6 0.2 194 114 
34 17.9 0.5 0.2 74 109 
35 23.5 0.6 0.2 68 134 
36 9.2 0.5 0.2 90 120 
37 19.2 0.6 0.2 89 103 
38 20.9 0.6 0.2 99 64 
39 22.4 0.6 0.2 69 79 
4 12.7 0.3 2 207 54 
40 23.5 0.6 0.2 132 108 
41 23.3 0.6 0.2 53 64 
42 23.3 0.6 0.2 102 117 
43 17.1 0.3 0.2 59 50 
44 20.7 0.6 0.2 97 112 
45 18.4 0.4 0.2 85 74 
46 21.8 0.6 0.2 72 93 
47 23.6 0.5 0.2 104 206 
48 19.1 0.7 0.2 124 75 
49 21.3 0.5 0.2 277 188 
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Table 26. Post-transport plasma chemistry data collected during the dose response trial: part three 
# Globulins (g/dl) A/Gratio GGT (U/l) Mg (meq/l) 
1 2.6 1.19 104 2.6 
10 3.2 0.94 89 2.1 
11 2.6 1.19 95 2.4 
12 2.9 1.17 94 2.5 
13 3 1.1 98 2.5 
14 2.6 1.42 63 2.3 
15 2.4 1.13 85 2 
16 2.8 1.21 87 1.9 
17 2.5 1.28 85 2.5 
18 3.5 0.94 150 2.3 
19 2.8 1.21 84 2.2 
2 3 1 97 2 
20 2.6 1.15 81 2.2 
21 3 1.07 138 2.4 
22 3.1 1.13 67 2.5 
23 2.6 1.38 70 2.3 
24 2.7 1.22 90 2.4 
25 3.3 0.94 108 2 
26 3.4 0.91 105 2.2 
27 2.8 1.21 86 2.6 
28 3.1 1.19 92 2.6 
29 2.5 1.4 55 2.5 
3 2.7 1 79 2 
30 3 1.03 8 2.1 
31 2.4 1.04 69 2.1 
32 2.6 1.23 69 2.3 
33 2.6 1.19 110 2.2 
34 1.7 1.29 102 1.4 
35 2.8 0.96 104 1.9 
36 2.7 1.3 70 2.2 
37 3 1.17 86 2.1 
38 2.9 1.14 47 2.2 
39 2.1 1.38 58 2 
4 2.2 0.91 44 1.5 
40 2.6 1.12 103 2.3 
41 2.2 1.14 75 1.8 
42 2.9 1.21 70 2.2 
43 1.7 1.29 45 1.3 
44 2.9 0.97 75 2.3 
45 4.3 0.67 149 1.8 
46 2.4 1.21 82 2.1 
47 2.6 1.27 157 2 
48 2.7 1.19 83 2.1 
49 2.3 1.26 111 2.1 
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Table 27. Post-transport electrolyte data collected during the dose response trial 
   # Na (meq/l) K (meq/l) Na/K ratio Cl (meq/l) 
1 150 6 25 113 
10 142 4.8 29.6 107 
11 144 4.7 30.6 110 
12 147 4.7 31.3 113 
13 146 4.8 30.4 113 
14 144 5.1 28.2 108 
15 127 4.5 28.2 99 
16 133 4.4 30.2 100 
17 142 4.8 29.6 109 
18 141 4.6 30.7 107 
19 140 4.3 32.6 107 
2 139 4.4 31.6 105 
20 142 4.5 31.6 108 
21 143 4.5 31.8 108 
22 144 4.3 33.5 108 
23 145 4.8 30.2 108 
24 140 4.7 29.8 111 
25 136 4.6 29.6 105 
26 142 4.6 30.9 109 
27 142 4.4 32.3 109 
28 144 4.7 30.6 110 
29 139 4.5 30.9 106 
3 126 4.1 30.7 97 
30 135 4.3 31.4 102 
31 119 4.1 29 91 
32 145 5.3 27.4 110 
33 132 4.5 29.3 101 
34 97 3.2 30.3 72 
35 126 4.1 30.7 94 
36 141 4.7 30 107 
37 142 4.9 29 108 
38 139 5.2 26.7 104 
39 120 3.6 33.3 91 
4 99 3.6 27.5 76 
40 141 4.4 32 109 
41 127 4 31.8 95 
42 140 5.2 26.9 103 
43 93 3.1 30 71 
44 131 4.2 31.2 100 
45 133 4.5 29.6 98 
46 132 4.1 32.2 100 
47 134 4.1 32.7 102 
48 131 4.4 29.8 98 
49 128 4.3 29.8 98 
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Table 28. Treatment, sex, and weights of sheep during second summer (a) 
Treatment 
# Sex Sheep # Weight 1 Weight 2  Weight 3 
1 M 1 18.14 21.55 19.28 
1 F 10 33.11     
1 F 11 34.47 37.19 34.70 
1 F 12 42.18 47.40 42.86 
1 F 13 39.92 40.37 38.10 
1 M 14 27.22 32.66 30.39 
1 M 15 18.60 22.45 20.87 
1 M 16 19.50 23.59 21.77 
1 M 17 27.67 34.47 31.52 
1 M 18 19.50 24.95 23.59 
1 M 19 12.25 17.46 15.88 
2 M 2 21.32 29.03 26.31 
2 F 20 32.66 34.70 31.30 
2 F 21 32.20 32.89 29.48 
2 F 22 36.29 36.29 33.57 
2 F 23 33.57 33.57 29.94 
2 M 24 21.32 26.76 24.04 
2 M 25 15.88 19.73 18.60 
2 M 26 19.96 27.22 24.49 
2 M 27 15.88 22.23 19.28 
2 M 28 17.24 33.34 29.94 
2 M 29 17.24 23.36 21.32 
3 M 3 19.50 26.31 23.13 
3 F 30 32.66 36.06 32.89 
3 F 31 39.01 43.77 38.10 
3 F 32 37.65 39.01 36.74 
3 F 33 31.30 33.34 31.52 
3 M 34 22.23 26.31 24.27 
3 M 35 15.42 21.77 20.41 
3 M 36 23.59 29.03 24.04 
3 M 37 22.68 27.44 25.17 
3 M 38 25.85 33.11 30.62 
3 M 39 24.04 27.90 25.85 
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Table 29. Treatment, sex, and weights of sheep during second summer (b) 
Treatment 
# Sex Sheep # Weight 1 Weight 2  Weight 3 
4 M 4 12.25 17.46 16.10 
4 F 40 41.28 45.13 41.96 
4 F 41 32.20 36.29 33.57 
4 F 42 25.85 30.62 27.67 
4 F 43 25.85 30.16 28.12 
4 M 44 16.33 17.92 17.24 
4 M 45 14.51 20.87 17.46 
4 M 46 19.50 27.22 22.23 
4 M 47 24.49 30.16 27.67 
4 M 48 14.06     
4 M 49 18.14 24.49 21.55 
5 M 5 23.59 28.12 26.31 
5 F 50 35.38 39.46 35.38 
5 F 51 33.57 30.39 29.26 
5 F 52 29.94 33.57 30.39 
5 F 53 37.65 43.32 39.01 
5 M 54 19.96 27.44 24.72 
5 M 55 24.95 30.84 28.12 
5 M 56 20.87 26.31 24.27 
5 M 57 24.04 30.39 28.35 
5 M 58 21.32 27.22 24.95 
5 M 59 20.41 27.22 24.72 
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Table 30. Observed latency to drink (sec) 
post transport during the component trial 
Sheep # Drink Sheep # Drink 
1   4 563 
10   40 1273 
11 801 41   
12 1219 42 627 
13 489 43 1200 
14 450 44   
15 22 45 360 
16   46 359 
17 327 47 410 
18 1024 48   
19 1604 49 549 
2 516 5 17 
20 511 50 296 
21 1720 51   
22 1154 52 478 
23 1636 53 84 
24 772 54 612 
25 279 55 253 
26 1017 56 709 
27 258 57 564 
28 12 58 398 
29 846 59 849 
3 24     
30 1821     
31 807     
32 877     
33 1564     
34 10     
35 510     
36 386     
37 18     
38 631     
39 555     
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Table 31. Cortisol data collected during the component trial (a) 
 # -21 d 
0h 
transport 
4h 
transport 
8h 
transport 
1 0.55 1.02 0.48 1.76 
10         
11 7.12 2.68 2.03 0.69 
12 2.59 0.21 2.61 0.10 
13 0.20 2.04 4.54 4.81 
14 0.58 0.44 0.42 0.24 
15 2.65 0.68 0.71 0.45 
16 2.82 0.94 1.18 2.24 
17 0.47 1.23 2.63 3.86 
18 3.67 0.46 3.11 0.45 
19 0.67 0.45 1.80 0.28 
2 0.47 0.99 1.20 0.94 
20 3.17 1.55 0.89 1.70 
21 1.11 0.81 1.69 0.26 
22 3.92 0.68 0.48 4.26 
23 7.65 4.43 0.36 0.46 
24 0.99 0.78 0.83 1.58 
25 0.73 0.97 0.49 6.81 
26 0.33 0.90 1.12 0.41 
27 0.56 0.79 4.16 1.23 
28 1.10 2.01 1.82 0.38 
29 1.52 0.85 4.07 0.42 
3 0.69 1.57 0.76 2.18 
30 0.97 1.17 2.26 1.32 
31 2.38 0.76 0.49 0.38 
32 2.77 2.32 0.97 1.12 
33 0.92 2.38 0.33 1.63 
34 0.68 0.63 2.24 0.33 
35 0.67 0.65 1.42 0.31 
36 0.51 0.46 1.41 0.28 
37 3.57 0.70 1.50 0.21 
38 0.67 0.52 2.14 0.39 
39 1.79 1.56 0.74 0.32 
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Table 32. Cortisol data collected during the component trial (b) 
#  -21 d 
0h 
transport 
4h 
transport 
8h 
transport 
4 0.61 0.58 1.58 0.32 
40 0.91 0.83 0.47 0.26 
41 2.71 0.53 5.00 0.15 
42 3.52 1.80 1.36 0.50 
43 2.73 4.95 1.00 0.34 
44 2.00 1.62 4.24 1.78 
45 0.44 0.20 1.52 1.05 
46 0.40 0.48 1.04 2.60 
47 0.57 1.13 0.90 1.57 
48         
49 1.35 0.60 6.40 0.52 
5 1.34 2.29 0.75 0.94 
50 2.29 0.91 0.39 2.55 
51 4.92 0.83 7.20 5.35 
52 3.24 6.67 4.35 4.96 
53 3.70 4.24 0.53 0.34 
54 0.80 0.62 3.17 0.41 
55 1.55 2.80 0.45 4.40 
56 0.60 0.93 3.05 1.19 
57 0.52 1.52 0.19 0.65 
58 0.60 0.66 3.18 0.58 
59 0.98 2.01 4.31 1.31 
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Table 33. Aldosterone data (ng/dl) collected during the component 
trial (a) 
# -21 d 
Pre- 
transport Post transport 
1 26.93 12.90 3.34 
10       
11 4.18 2.27 1.51 
12 42.25 4.77 4.63 
13 7.75 8.42 1.27 
14 10.95 5.59 7.32 
15 5.67 3.40 6.06 
16 15.18 10.10 2.28 
17 5.73 2.33 14.66 
18 8.67 3.30 6.68 
19 6.59 2.04 3.04 
2 4.89 3.88 1.11 
20 12.37 7.30 5.58 
21 7.60 3.99 2.58 
22 17.93 1.03 1.78 
23 6.28 1.93 6.67 
24 7.06 0.83 12.20 
25 22.73 14.85 13.78 
26 7.01 6.45 2.87 
27 7.32 0.50 7.77 
28 12.31 0.72 21.78 
29 17.10 15.66 10.26 
3 8.14 0.33 0.80 
30 5.98 3.67 10.94 
31 9.58 1.48 1.61 
32 18.77 10.00 4.68 
33 17.99 6.96 11.82 
34 5.51 0.80 10.91 
35 4.49 15.80 10.40 
36 5.73 5.52 5.30 
37 8.92 2.41 16.98 
38 1.92 2.12 5.22 
39 9.80 16.62 1.76 
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Table 34. Aldosterone data (ng/dl) collected during the component 
trial (b) 
# -21 d 
Pre- 
transport Post transport 
4 3.52 4.88 19.68 
40 15.14 4.44 25.31 
41 6.50 6.56 7.81 
42 3.17 5.44 8.56 
43 19.58 13.50 2.93 
44 14.65 3.89 8.45 
45 13.09 4.84 3.11 
46 15.29 6.89 5.27 
47 1.54 1.31 11.42 
48       
49 4.16 1.92 8.16 
5 11.93 14.38 3.00 
50 11.53 7.60 9.04 
51 21.61 16.24 9.61 
52 11.81 22.46 3.77 
53 25.67 14.41 8.67 
54 4.32 4.54 5.00 
55 6.94 2.15 2.30 
56 19.55 7.26 20.56 
57 4.21 5.87 1.32 
58 15.96 2.96 1.85 
59 1.98 4.49 10.01 
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Table 35. IgG and IgM (abs 450nm) data collected during the component trial (a) 
# IgG d11 IgG d15 IgG d18 IgM d11 IgM d15 IgM d18 
1 0.08 0.53 0.61 1.08 0.70 1.16 
10             
11       1.05 0.83 1.41 
12       1.10 0.77 1.31 
13       1.27 0.83 2.35 
14 0.06 0.43 0.39 0.97 0.66 1.02 
15 0.42 0.96 1.02 1.01 0.69 1.45 
16 0.15 0.58 1.06 1.22 0.84 2.78 
17 0.07 0.51 0.11 1.07 0.70 1.19 
18 0.14 0.72 0.89 0.93 1.19 1.05 
19 0.12 0.67 0.78 1.00 1.24 1.09 
2 0.22 0.88 0.67 1.06 1.39 1.77 
20 0.25 0.44 0.23 1.15 1.38 1.57 
21 0.35 0.93 1.23 0.95 1.39 1.08 
22 0.21 0.56 0.55 1.10 1.39 1.39 
23 0.11 0.71 0.65 1.10 1.31 1.27 
24 0.20 0.54 0.23 1.02 1.08 1.17 
25 0.36 0.87 0.57 1.04 1.33 1.28 
26 0.16 0.73 0.86 1.03 1.21 1.12 
27 0.15 0.66 1.01 1.05 1.03 1.23 
28 0.24 0.69 0.62 1.06 1.38 1.75 
29 0.18 0.66 1.14 1.02 1.07   
3 0.15 0.62 0.25 1.02 0.98 2.24 
30 0.30 0.83 1.35 1.07 1.13 1.63 
31 0.15 0.68 0.49 1.04 1.32 1.87 
32 0.23 0.82 0.91 1.33 0.67 2.00 
33 0.16 0.60 0.42 1.40 0.77 1.17 
34 0.40 0.88 1.36 1.27 0.68 1.59 
35 0.11 0.49 0.34 1.78 0.57 1.38 
36 0.12 0.62 0.31 0.95 0.84 1.05 
37 0.07 0.49 0.23 1.01 0.61 1.56 
38 0.23 0.90 0.91 1.06 0.62 1.35 
39 0.18 0.72 0.87 1.14 0.45 1.40 
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Table 36. IgG and IgM (abs 450nm) data collected during the component trial (b) 
# IgG d11 IgG d15 IgG d18 IgM d11 IgM d15 IgM d18 
4 0.17 0.72 0.67 0.69 1.37 1.39 
40 0.15 0.48 0.56 1.46 1.51 1.42 
41 0.17 0.61 1.08 1.08 1.36 1.04 
42 0.30 0.61 0.91 0.88 1.53 1.38 
43 0.14 0.74 0.42 0.63 1.14 0.89 
44 0.19 0.75 0.87 1.16 1.31 1.38 
45 0.16 0.63 0.85 0.78 1.23 1.08 
46 0.14 0.90 0.71 0.72 0.89 1.44 
47 0.10 0.72 0.66 0.78 0.93 1.38 
48             
49 0.10 0.82 0.44 0.94 0.94 1.28 
5 0.30 0.58 0.24 0.62 1.02 1.00 
50 0.11 0.63 0.41 0.87 1.10 1.20 
51 0.09 0.66 0.31 0.76 1.01 1.21 
52 0.42 1.01 0.94 0.69 1.22 0.84 
53 0.32 0.72 0.24 1.19 0.84 1.93 
54 0.17 0.63 0.30 0.65 1.31 0.93 
55 0.24 1.25 1.18 2.44 3.29 1.07 
56 0.24 1.16 1.74 2.52 1.35 1.63 
57 0.12 0.65 0.37 1.22 1.94 1.88 
58 0.12 0.55 0.97 1.15 1.46 1.62 
59 0.07 0.99 0.67 0.98 1.05 1.08 
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Table 37. Complete blood cell count data collected during the component trial: part one (a) 
# WBC RBC PCV Hemoglobin MCV MCH MCHC 
1 9600 8.09 22.3 7.69 27.6 9.5 34.5 
10               
11 7600 7.96 24.4 8.01 30.7 10.1 32.8 
12 5500 10.5 29.3 10.2 27.9 9.7 34.8 
13 7800 11.3 28.8 9.78 25.5 8.7 34 
14 6700 10.1 30.9 10.5 30.6 10.4 34 
15 4400 10.6 29.9 10.2 28.2 9.6 34.1 
16 6900 10.1 28.4 10.1 28.1 10 35.6 
17 5800 9.52 27 9.14 28.4 9.6 33.9 
18 4000 9.23 30.6 10.3 33.2 11.2 33.7 
19 6100 9.53 28.2 9.88 29.6 10.4 35 
2 2700 9.33 28.5 9.49 30.5 10.2 33.3 
20 2400 10.1 28.1 9.87 27.8 9.8 35.1 
21 2400 9.59 29.1 9.9 30.3 10.3 34 
22 8200 9.32 25.1 8.65 26.9 9.3 34.5 
23 5300 10.4 27.1 9.25 26.1 8.9 34.1 
24 8400 11.2 31.6 11.2 28.2 9.6 34.2 
25 8200 11.1 32.1 10.9 28.9 9.8 34 
26 5100 9.31 28.3 10.1 30.4 10.8 35.7 
27 3400 9.13 27.1 10 29.7 11 36.9 
28 3700             
29 5000 10.8 29.1 10.1 26.9 9.4 34.7 
3 4200 7.74 27.7 9.24 35.8 11.9 33.4 
30 6000 11.7 30.1 10.6 25.7 9.1 35.2 
31 8400 9.98 26.1 8.79 26.2 8.8 33.7 
32 3800 9.33 24.6 8.17 26.4 8.8 33.2 
33 9200 9.71 26.8 9.39 27.6 9.7 35 
34 5100 9.31 26.8 9.34 28.8 10 34.9 
35 4900 11.5 32.5 11.3 28.3 9.8 34.8 
36 7700 10.1 29.7 10.3 29.4 10.2 34.7 
37 4900 10.4 30.1 10.7 28.9 10.3 35.5 
38 3800             
39 8100 9.42 27 9.38 28.7 10 34.7 
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Table 38. Complete blood cell count data collected during the component trial: part one (b) 
# WBC RBC PCV Hemoglobin MCV MCH MCHC 
4 4800 10.1 30.4 10.3 30.1 10.2 33.9 
40 5700 11.7 30.9 10.8 26.4 9.2 35 
41 6900 11.2 32.1 11.1 28.7 9.9 34.6 
42 3200 9.01 29.6 10.3 32.9 11.4 34.8 
43 10100 8.22 24.2 8.53 29.4 10.4 35.2 
44 5700 11 32.3 11.8 29.4 10.7 36.5 
45 3600 8.77 29.4 9.86 33.5 11.2 33.5 
46 1500             
47 6300 10.4 30.7 10.3 29.5 9.9 33.6 
48               
49 5400 9.72 29.8 10.3 30.7 10.6 34.6 
5 4000 9.63 29.6 10.4 30.7 10.8 35.1 
50 4000 9.65 24.3 8.34 25.2 8.6 34.3 
51 9200 8.62 24.7 8.24 28.7 9.6 33.4 
52 3200 6.81 22.4 7.38 32.9 10.8 32.9 
53 8400 11.9 28.4 10.1 23.9 8.5 35.6 
54 4300             
55 4100 12.3 35.6 12 28.9 9.8 33.7 
56 5400 9.83 27.7 9.89 28.2 10.1 35.7 
57 6900 8.85 27.5 9.36 31.1 10.6 34 
58 3300 9.13 27 9.39 29.6 10.3 34.8 
59 1800             
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Table 39. Complete blood cell count data collected during the component trial: part two (a) 
# Eosoniphils Basophil Monocyte Neutrophil P. protein Lymphocytes Fibrinogen 
1 864 96   4224 6.5 4416 600 
10               
11 1292     2888 6.9 3420 400 
12 605     1430 7.5 3465 500 
13 546   78 3042 8.2 4134 500 
14 67 67   2546 6.2 3819 200 
15       1672 6.6 2728 300 
16       4623 6.4 2277 200 
17 58 58 58 1160 6.9 4466 500 
18       1080 6.3 2920 200 
19 122     2074 6.3 3904 300 
2 54     675 6.5 1971 300 
20 24     1032 7.1 1344 500 
21 72     504 7 1824 200 
22 492   82 5330 8.2 2296 800 
23 159 106   2756 8.2 2279 600 
24 84 84 168 4956 6.2 3108 100 
25       2460 6.4 5740 200 
26 51 51 255 2601 6 2142 400 
27   68 34 1292 5.7 2006 200 
28   37 74 962   2627   
29 50 50 50 1800 6.2 3050 100 
3 84     1512 6 2604 300 
30 300 60 180 3240 7 2220 400 
31 168 168 336 2772 7.6 4956 300 
32     76 2394 7.4 1330 500 
33 92     2484 7.6 6624 400 
34     51 2499 6.5 2550 500 
35 98     2352 6.4 2450 400 
36       1771 6.3 5929 300 
37       1372 6.2 3332 100 
38 152   38 1406   2204   
39 162     3159 6.1 4779 300 
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Table 40. CBC Complete blood cell count data collected during the component trial: part two (b) 
# Eosoniphils Basophil Monocyte Neutrophil P. protein Lymphocytes Fibrinogen 
4 192     2304 6.6 2304 200 
40 114     1824 7.2 3762 500 
41 483     1932 7 4485 400 
42 32     896 7.1 2272 300 
43   101   4646 6.4 5353 400 
44 171   57 1995 6.6 3477 400 
45 36   36 1728 5.7 1800 200 
46     60 480   960   
47   252 126 3150 6.2 2772 200 
48               
49 108 54 108 3402 6.2 1728 200 
5       1280 5.7 2720 100 
50 40   240 1120 6.6 2600 400 
51     644 7544 5.7 1012 200 
52 32   64 1376 6.5 1728 300 
53 840 168 672 2688 7.5 4032 500 
54 86   86 602   3483   
55 82 41 82 2624 6.9 1271 500 
56 378 108 54 1296 7 3564 100 
57 759 69 207 1794 6.2 4071 500 
58 231   66 1287 5.8 1716 200 
59 36   36 576   1152   
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Table 41. Electrolyte concentrations collected before and after transport during the component trial (a) 
  _______Electrolytes before transport____ _______Electrolytes after transport_____ 
Sheep # Na K 
Na/K 
ratio Cl Na K 
Na/K 
ratio Cl 
1 144 4.8 30 110 148 4.6 32.2 113 
10                 
11 144 4.6 31.3 110 145 4.4 33 109 
12 146 4.3 34 109 151 4.9 30.8 111 
13 146 4.7 31.1 109 152 4.9 31 109 
14 145 4.7 30.9 111 149 4.9 30.4 113 
15 144 4.8 30 110 149 4.7 31.7 112 
16 143 4.5 31.8 109 149 5 29.8 111 
17 145 4.4 33 110 147 4.6 32 111 
18 143 4.8 29.8 108 146 4.6 31.7 110 
19 144 4.6 31.3 110 149 4.6 32.4 111 
2 145 4.9 29.6 110 151 4.8 31.5 112 
20 148 4.9 30.2 116 147 5.6 26.3 113 
21 147 4.4 33.4 111 148 4.5 32.9 112 
22 143 4.5 31.8 109 147 4.3 34.2 105 
23 144 4.5 32 108 150 4.1 36.6 110 
24 143 5 28.6 111 150 4.2 35.7 115 
25 145 4.7 30.9 110 147 5.2 28.3 110 
26 144 4.8 30 110 146 4.7 31.1 113 
27 139 4.7 29.6 108 148 4.8 30.8 113 
28 145 5.2 27.9 111 148 4.4 33.6 113 
29 144 4.7 30.6 110 147 4.4 33.4 111 
3 143 5.3 27 109 151 5.2 29 110 
30 147 4.9 30 107 151 4.9 30.8 106 
31 145 4.6 31.5 108 149 4.5 33.1 109 
32 145 5 29 106 153 4 38.3 110 
33 146 4.5 32.4 108 149 4.5 33.1 106 
34 143 4.5 31.8 109 150 4 37.5 112 
35 146 4.7 31.1 113 153 5.9 25.9 112 
36 144 5 28.8 109 147 4.7 31.3 107 
37 143 5 28.6 110 148 4.7 31.5 111 
38 144 4.8 30 109 149 4.2 35.5 110 
39 142 4.7 30.2 107 147 4.3 34.2 108 
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Table 42. Electrolyte concentrations collected before and after transport during the component trial (b) 
  _______Electrolytes before transport____ _______Electrolytes after transport_____ 
Sheep # Na K 
Na/K 
ratio Cl Na K 
Na/K 
ratio Cl 
4 145 4.9 29.6 110 146 4.5 32.4 109 
40 147 4.9 30 109 149 4.8 31 108 
41 147 4.5 32.7 111 147 4.9 30 108 
42 140 4.3 32.6 106 151 4.6 32.8 111 
43 143 4.4 32.5 110 153 4.3 35.6 114 
44 146 5.3 27.5 111 152 5.1 29.8 114 
45 143 4.7 30.4 111 149 4.8 31 114 
46 142 4.5 32.6 110 149 4.1 36.3 115 
47 145 4.6 31.5 112 150 4.7 31.9 113 
48                 
49 143 4.6 31.1 108 149 4.3 34.7 111 
5 145 4.5 32.2 110 150 4 37.5 113 
50 144 4.6 31.3 107 148 4.4 33.6 110 
51 147 4.2 35 111 159 3.8 41.8 117 
52 149 5 29.8 112 153 4.5 34 114 
53 146 4.6 31.7 112 154 4.5 34.2 117 
54 144 5 28.8 112 152 4.5 33.8 115 
55 145 4.4 33 111 151 4.9 30.8 114 
56 145 4.8 30.2 111 148 4.4 33.6 110 
57 145 4.8 30.2 110 149 4.9 30.4 113 
58 144 4.8 30 111 149 4.6 32.4 113 
59 144 4.5 32 110 150 5.4 27.8 113 
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Table 43. Temperature data (˚C) collected during the component trial 
Sheep # Maximum Minimum Sheep # Maximum Minimum 
1 38.6 37.9 4     
10     40 38.4 36.1 
11 38.8 37.5 41 38.5 36.8 
12 38.0 36.0 42 38.8 37.9 
13   36.0 43 39.0 36.3 
14 38.9 38.4 44 38.8 37.0 
15     45 39.1 37.6 
16 38.6   46 38.8 38.1 
17 38.1   47     
18 38.6 37.5 48     
19 39.0 37.5 49     
2 39.6   5 38.5 37.9 
20 39.0 37.0 50 38.5 37.0 
21 38.2 37.1 51 38.9 36.9 
22 37.9 36.3 52 38.4 37.1 
23 38.5 37.5 53 37.9 36.6 
24     54 39.1   
25     55 38.9   
26     56 39.5   
27     57 38.9 38.0 
28   37.1 58 39.3   
29 38.9 37.4 59 38.6 34.9 
3 38.8 37.9       
30 38.1         
31 38.1 37.1       
32 39.0 37.1       
33           
34 39.1         
35 38.8         
36           
37           
38 39.4 36.5       
39 38.9 36.3       
 
 
 
                                                                                                                                           117
VITA 
Name:      Gregory Scott Archer 
 
Permanent Address:    551 Old Stage Rd 
              Glen Burnie, MD 21061 
 
Educational Background:  Virginia Polytechnic and State University 
  B.S. in Animal and Poultry Sciences 
 
    Texas A&M University 
     M.S. in Animal Science 
 
Major Field of Specialization: Applied Ethology / Stress Physiology 
 
Professional Organizations:  International Society of Applied Ethology (ISAE) 
      American Society of Animal Science (ASAS) 
 
 
